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Notice to Readers
This Audit Risk Alert, prepared by the AICPA staff, is intended
to provide auditors of financial statements of health care organi-
zations with an overview of recent economic, industry, regula-
tory, and professional developments that may affect the audits
they perform.
This publication is an Other Auditing Publication as defined in
Statement on Auditing Standards (SAS) No. 95, Generally Accepted
Auditing Standards (AICPA, Professional Standards, vol. 1, AU sec.
150). Other Auditing Publications have no authoritative status;
however, they may help the auditor understand and apply SASs.
If an auditor applies the auditing guidance included in an Other
Auditing Publication, he or she should be satisfied that, in his or
her judgment, it is both appropriate and relevant to the circum-
stances of his or her audit. The auditing guidance in this docu-
ment has been reviewed by the AICPA Audit and Attest Standards
staff and published by the AICPA and is presumed to be appro-
priate. This document has not been approved, disapproved, or
otherwise acted on by a senior technical committee of the AICPA.
Maryann Kasica, CPA
Technical Manager
Accounting and Auditing Publications
Copyright © 2003 by
American Institute of Certified Public Accountants, Inc.
New York, NY 10036-8775
All rights reserved. For information about the procedure for requesting 
permission to make copies of any part of this work, please call the AICPA 
Copyright Permissions Hotline at (201) 938-3245. A Permissions Request Form
for e-mailing requests is available at www.aicpa.org by clicking on the copyright
notice on any page. Otherwise, requests should be written and mailed to the 
Permissions Department, AICPA, Harborside Financial Center, 201 Plaza Three,
Jersey City, NJ 07311-3881. 
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1Health Care Industry Developments—2003/04
How This Alert Helps You
This Audit Risk Alert helps you plan and perform your health
care industry audits. The knowledge delivered by this Alert assists
you in achieving a more robust understanding of the business and
economic environment in which your clients operate. This Alert
is an important tool in helping you identify the significant risks
that may result in the material misstatement of your client’s fi-
nancial statements. Moreover, this Alert delivers information
about emerging practice issues and about current accounting, au-
diting, and regulatory developments.
If you understand what is happening in the health care industry
and you can interpret and add value to that information, you will
be able to offer valuable service and advice to your clients. This
Alert assists you in making considerable strides in gaining that in-
dustry knowledge and understanding it.
This Alert is intended to be used in conjunction with the AICPA
general Audit Risk Alert—2003/04 (product no. 022334kk). You
should refer to the full text of the accounting and auditing pro-
nouncements as well as the full text of any rules or publications
that are discussed in this Alert.
Economic and Industry Developments
Statement on Auditing Standards (SAS) No. 22, Planning and
Supervision (AICPA, Professional Standards, vol. 1, AU sec. 311),
among other matters, provides guidance for auditors regarding
the specific procedures that should be considered in planning an
audit in accordance with generally accepted auditing standards
(GAAS). SAS No. 22 states that the auditor should obtain a
knowledge of matters that relate to the nature of the entity’s busi-
ness, its organization, and its operating characteristics, and con-
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sider matters affecting the industry in which the entity operates,
including, among other matters, economic conditions as they re-
late to the specific audit.
For a thorough discussion of the economic and business environ-
ment, see the AICPA general Audit Risk Alert—2003/04.
Federal legislators continued to focus on health care issues in
2003, and on December 8, 2003, the Medicare Prescription
Drug, Improvement and Modernization Act of 2003 was signed
into law.
Health care organizations continue to deal with business pres-
sures faced in prior years, as well as new pressures. These pressures
include:
• Market pressures to provide quality health care at reason-
able costs.
• The hiring and retention of professional nursing staff.
While companies in a number of industries are cutting
jobs, nursing shortages and the hiring and retention of
qualified medical staff continue to be the focus for many
health care organizations.
• Keeping up with regulatory requirements, including com-
pliance with the Administrative Simplification provisions
of the Health Insurance Portability and Accountability Act
of 1996 (HIPAA). (See the related discussions “The Health
Insurance Portability and Accountability Act of 1996” in
the “Regulatory Developments” section of this Alert, and
“Implementing Health Insurance Portability and Account-
ability Act Requirements” in the “Audit Issues and Devel-
opments” section of this Alert.) Also, a number of new final
rules were issued in 2003 by the Securities and Exchange
Commission (SEC) to implement the requirements of the
Sarbanes-Oxley Act of 2002. For a discussion of the Sar-
banes-Oxley Act of 2002 and SEC regulatory develop-
ments, see the AICPA general Audit Risk Alert—2003/04.
• The billing of charges and the collection process for unin-
sured patients. (See the related discussion “Collectibility of
2
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3Receivables” in the “Audit Issues and Developments” sec-
tion of this Alert.)
• States are experiencing moderate to severe budget funding
issues. As a result of state spending cuts or other actions to
address these funding issues, payments to health care orga-
nizations from Medicaid or other state sources may be at
risk. These risks can be expressed in a number of ways,
such as benefit changes, program eliminations, lower fund-
ing levels (for federal match), higher eligibility require-
ments, and slower payment cycles. Auditors of health care
organizations that may be affected by these changes should
consider the impact of these risks when auditing estimates
for revenues and receivables from these sources, including
estimates for bad debt.
• Complexity of negotiated contacts with payers and the re-
lated difficulty of properly estimating and accounting for
revenue under these arrangements.
• Many health care systems and managed care companies are
significantly changing risk profiles in provider contracts.
Auditors should consider the effect of these risk contract
changes, either to full risk or away from full risk, on the fi-
nancial statements when auditing their health care indus-
try clients, and consider the need to perform additional
auditing procedures, including a careful review of the con-
tract terms.
• High outlier payments to a number of health care organi-
zations from Medicare. Thomas A. Scully, Administrator,
Centers for Medicare and Medicaid Services (CMS), in
testimony before the Senate Appropriations Subcommittee
on Labor, Health and Human Services, and Education on
March 11, 2003, stated that the inpatient prospective pay-
ment system (PPS) outlier policy, prior to publication of a
new proposed rule, had a couple of major problems that al-
lowed hospitals to claim excessive outlier payments. A dis-
cussion of the problems and corrective actions, including
comprehensive field audits, which were taken upon discov-
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ery of abuse of Medicare’s outlier policy, can be found in
the testimony. (The testimony can be found on the CMS
Web site at www.cms.gov. Also, see the related discussion
of the new CMS rule revising the methodology for deter-
mining outlier payments in “Cost Outliers” in the “Regu-
latory Developments” section of this Alert.)
• Rising costs for malpractice claims. (See the related discus-
sion “Malpractice Losses” in the “Audit Issues and Devel-
opments” section of this Alert.)
• Other-than-temporary losses on investments held by not-
for-profit health care organizations. (See the related discus-
sions “Technical Practice Aid, Other-than-Temporary
Impairment Losses on Investments by Not-for-Profit Health
Care Organizations” in the “New Accounting Pronounce-
ments and Other Guidance” section of this Alert, and
“EITF Issue No. 03-1, The Meaning of Other-Than-Tempo-
rary Impairment and Its Application to Certain Investments”
in the “On the Horizon” section of this Alert.)
• For for-profit health care organizations, providing opti-
mum returns to shareholders.
Regulatory Developments1
This section of the Alert provides brief summaries of some of the
regulations issued and regulatory publications released since the
writing of last year’s Alert that may affect your clients in the
health care industry.
Auditors may need to monitor changes in government regulations
for various reasons. For example, health care organizations that are
providers of services to patients covered under Medicare or other
4
1. Readers should be alert for updates, amendments, or other changes to the rules dis-
cussed in this section of the Alert and other recent developments related to regula-
tory activities. The brief summaries provided in this section of the Alert are for
informational purposes only. Readers should refer to the full text of the regulations
and other documents that are discussed in this section of the Alert. See the “Infor-
mation Sources” section at the end of this Alert for a list of some Web sites that can
provide additional information on regulatory issues and developments.
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5federal health care programs have potential exposure to fines and
penalties as a result of laws and regulations governing the billing
and cost-reporting process. As another example, auditors of health
care organizations may be required to comply with government
auditing standards, as specified in Government Auditing Standards.
(See the related discussion about the comprehensive revision to
Government Auditing Standards and the independence rules in
Government Auditing Standards in “Government Auditing Stan-
dards Developments” in this section of this Alert.) Also, since the
writing of last year’s Alert, the SEC has issued a number of rules to
implement the requirements of the Sarbanes-Oxley Act of 2002.
Note: For information about recent SEC and Public Company
Accounting Oversight Board (PCAOB) regulatory activities,
see the AICPA general Audit Risk Alert—2003/04.
The Health Insurance Portability and Accountability Act of 1996
Health care organizations are implementing final rules that the
U.S. Department of Health and Human Services (HHS) has is-
sued to address certain Administrative Simplification provisions.
The Administrative Simplification provisions of HIPAA require
HHS to adopt national standards for electronic health care trans-
actions; unique identifiers for employers, providers, and health
plans; and security and privacy standards for health information.
Health plans, health care clearinghouses, and those health care
providers that conduct certain financial and administrative trans-
actions electronically (covered entities) are required to comply
with final standards.
Additional information about HIPAA, including information
about final rules issued in prior years to address the Administra-
tive Simplification provisions of HIPAA, is available on the HHS
Web site at www.hhs.gov. Final rules issued in prior years include
standards for privacy of individual health information, employer
identifier standards, and standards for electronic transactions and
code sets. Brief discussions about these rules were provided in last
year’s Alert. Also, see the related discussion “Implementing Health
Insurance Portability and Accountability Act Requirements” in
the “Audit Issues and Developments” section of this Alert.
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Security Standards
HHS published a final rule requiring implementation of admin-
istrative, physical, and technical standards to protect the confi-
dentiality, integrity, and availability of electronic protected health
information. The rule adopts implementation specifications that
provide instructions for implementing the standards. In cases
where the standard itself includes all the necessary instructions
for implementation, there may be no corresponding implementa-
tion specification, and the standards themselves serve as the im-
plementation specification.
The “Organizational Requirements” section of the rule provides
requirements for contracts between covered entities and business
associates. Among other requirements, the contract should pro-
vide that the business associate will implement safeguards that
reasonably and appropriately protect the confidentiality, in-
tegrity, and availability of the electronic protected health infor-
mation that the business associate creates, receives, maintains, or
transmits on behalf of the covered entity.
Covered entities (other than small health plans) have until April
21, 2005, to comply. Small health plans have until April 14,
2006, to comply. The final rule was published in the February 20,
2003, Federal Register.
Electronic Submission of Medicare Claims
The Administrative Simplification Compliance Act requires
Medicare providers to submit claims electronically by October
16, 2003, unless the requirement is waived. HHS published an
interim final rule in the August 15, 2003, Federal Register, that
implements the statutory requirement and identifies when
mandatory submission of electronic claims to Medicare is waived.
Prospective Payment Systems
Cost Outliers
CMS published a final rule revising the methodology for deter-
mining outlier payments to Medicare-participating hospitals
under the acute care hospital inpatient PPS for services to inpa-
6
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7tients for whom the cost of treatment greatly exceeds the fixed
payment under the inpatient PPS. The rule requires that after
October 1, 2003, the latest of either the most recently submitted
or the most recently settled cost report be used to calculate the
cost-to-charge ratio (CCR). Also among the final rule’s key provi-
sions, the use of statewide CCRs to determine a hospital’s costs
when the hospital’s own CCR falls below established parameters
is eliminated. CMS also revised the methodology to determine
payments made to Medicare-participating long-term care hospi-
tals under the long-term care hospital PPS for high-cost outliers
and short-stay outliers. The final rule was published in the June
9, 2003, Federal Register, effective August 8, 2003.
Additional information about this final rule and other CMS reg-
ulations and notices are available on the CMS Web site at
www.cms.gov. Also, see the related discussion “Prospective Pay-
ment System—Audit Considerations” in the “Audit Issues and
Developments” section of this Alert.
Physicians’ Referrals to Health Care Entities With 
Which They Have Financial Relationships 
As discussed in last year’s Alert, CMS published a final rule enti-
tled “Medicare and Medicaid Programs; Physicians’ Referrals to
Health Care Entities With Which They Have Financial Relation-
ships” in the January 4, 2001, Federal Register. This rule was ef-
fective January 4, 2002. In December 2001, CMS delayed the
effective date of the last sentence of Section 411.354(d)(1) of the
final rule for one year, until January 6, 2003, and in November
2002, further postponed the effective date of the last sentence
until July 7, 2003. In the April 25, 2003, Federal Register, CMS
published a final rule that again delays the effective date of the
last sentence of Section 411.354(d)(1), until January 7, 2004, to
avoid disruption of existing contractual arrangements for physi-
cian services.
Additional information about this final rule and other CMS reg-
ulations and notices is available on the CMS Web site at
www.cms.gov.
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Corporate Compliance
Compliance plans are voluntary for health care organizations un-
less imposed under a corporate integrity agreement by the HHS
Office of Inspector General (OIG). The OIG has issued compli-
ance program guidance in previous years for:
• Clinical laboratories.
• Hospitals.
• Home health agencies.
• Third-party medical billing companies.
• Hospices.




• Individual and small group physician practices.
In 2003, the OIG released “Final Compliance Program Guidance
for Ambulance Suppliers” and “Final Compliance Program
Guidance for Pharmaceutical Manufacturers.” You can get the
full text of the OIG compliance program guidance, as well as in-
formation on any compliance guidance that may be issued subse-
quent to the writing of this Alert, on the OIG Web site at
www.oig.hhs.gov/.
Audit Risk Alert Single Audits—2003
In previous years, the Health Care Organizations Audit Risk
Alerts have provided updates on developments on audits of fed-
eral awards (also known as single audits or Circular A-133 au-
dits). In 2003, the AICPA released the Audit Risk Alert Single
Audits—2003 (product no. 022453kk) for auditors of organiza-
tions receiving federal awards. Single Audits—2003 provides au-
ditors of organizations receiving federal awards with an overview
of recent industry, regulatory, and professional developments that
8
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9may affect the audits they perform. Although Government Audit-
ing Standards developments are discussed in Single Audits—2003,
this Alert also provides an update on Government Auditing Stan-
dards in the discussion “Government Auditing Standards Develop-
ments” that follows in this section of the Alert as many audits of
state and local government financial statements are required to be
performed under those standards, regardless of whether the entity
receives federal money. 
Government Auditing Standards Developments
Comprehensive Revision to Government Auditing Standards
The General Accounting Office (GAO) issued a comprehensive
revision to Government Auditing Standards (also known as the Yel-
low Book) in June 2003. This is the fourth revision of the overall
standards since they were first issued in 1972. This revision of the
standards supersedes the 1994 revision, including Amendments
No. 1 through No. 3 (note that the content of these amendments
was incorporated into the revision).
The revision affects all chapters of the Yellow Book, including
those relating to both financial and performance audits. Among
other things, the proposed changes are intended to clarify the
types of audits and services that are performed under the Yellow
Book, strengthen and streamline certain provisions of it, and im-
prove understandability of the standards. The revisions are effec-
tive for financial audits and attestation engagements of periods
ending on or after January 1, 2004, and for performance audits be-
ginning on or after January 1, 2004. Early application is permissi-
ble. Some of the more significant changes are that the revision:
• Adds a new chapter on attestation engagements that in-
cludes additional field work and reporting standards over
and above what would be required under the AICPA’s at-
testation standards.
• Requires that auditors collectively possess the technical
knowledge, skills, and experience necessary to be compe-
tent for the type of work being performed before begin-
ning the work on the assignment.
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• Clarifies that the 80 hours of continuing professional edu-
cation (CPE) and training that is required under the Yel-
low Book every two years should directly enhance the
auditor’s professional proficiency to perform audits and/or
attestation engagements. During the next year, the GAO is
expected to modify its existing Interpretation of Continuing
Education and Training Requirements—Government Audit-
ing Standards to more specifically address this new clarifi-
cation and whether certain courses would count toward
the 80-hour requirement.
• For financial statement audits, adds a requirement for au-
ditors to be alert to situations or transactions that could in-
dicate abuse, and if indications of abuse exist that could
significantly affect the financial statement amounts or
other financial data, to apply audit procedures specifically
directed to ascertain whether abuse has occurred and the
effect on the financial statement amounts or other finan-
cial data.
Independence
As discussed in last year’s Alert, Health Care Industry Develop-
ments 2002/03, Amendment No. 3, Independence, to Government
Auditing Standards, as affected by Government Auditing Stan-
dards: Answers to Independence Questions (a question-and-answer
document issued by the GAO), revises the independence stan-
dards in Government Auditing Standards for audits for periods be-
ginning on or after January 1, 2003. The independence rules in
Government Auditing Standards address when auditors and their
organizations are independent from the organizations they audit
by defining when personal, external, and organizational impair-
ments to independence exist.
Help Desk—You can obtain the new 2003 version of Govern-
ment Auditing Standards (which includes the independence re-
quirements from Amendment No. 3), the independence
question-and-answer document, and a summary of the signifi-
cant changes made since the 1994 revision of the standards
from the GAO Web site at www.gao.gov/govaud/ybk01.htm.
10
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Internal Revenue Service Developments
Private Activity Bonds
In 1997, the IRS published final regulations relating to the defini-
tion of private activity bonds and related rules under Internal Rev-
enue Code (IRC) secs. 103, 141, 142, 144, 145, 147, 148, and
150. The final rules reserved sec. 141.13 for rules regarding the ap-
plication of the private business tests and the private loan financing
test to refunding issues. In May 2003, the IRS published proposed
regulations, applicable to tax-exempt bonds issued by state and
local governments, regarding the application of the private business
tests and private loan financing test to refunding issues. Among
other matters, the proposed regulations would amend the regula-
tions under sec. 141, and provide that, in general, a refunding issue
and a prior issue are tested separately under sec. 141. The proposed
regulations would also amend regulations under secs. 145, 149, and
150 by proposing rules on certain related matters.
Proposed Guidance for Health Maintenance Organizations 
Notice 2003-31 announced that the U.S. Department of the
Treasury and the IRS intend to propose regulations providing
guidance under IRC sec. 501(m) that will define the term “com-
mercial-type insurance” and address how section 501(m) applies
to organizations described in IRC secs. 501(c)(3) and 501(c)(4),
including health maintenance organizations. Notice 2003-31
also requests comments on the content of the regulations to be
proposed and announces that in light of the regulations project,
the IRS is withdrawing from the IRS Manual the sections of Part
7.8.1, Chapter 27, Exempt Organizations Examination Guide-
lines Handbook, Health Maintenance Organizations that relate
to sec. 501(m) for further study.
Changes to Form 990 and Form 1023
Form 990. The IRS has proposed changes to the annual informa-
tion return, Form 990, Return of Organization Exempt from In-
come Tax. Furthermore, IRS Announcement 2002-87 brings
not-for-profits up to date on recent changes to Form 990. As of the
writing of this Alert, the IRS had not finalized the possible changes.
Readers should keep an eye out for these proposed changes.
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Form 1023. The IRS is revising Form 1023, Application for
Recognition of Exemption under IRC sec. 501(c)(3). As of the
writing of this Alert, the IRS had not yet published the revised
Form 1023. Readers should keep an eye out for the revised form.
Visit the IRS Web site at www.irs.gov to obtain updated informa-
tion regarding proposed regulations and other IRS developments.
Audit Issues and Developments2
Implementing Health Insurance Portability and 
Accountability Act Requirements
Alerts of recent years have noted that many health care organiza-
tions will need to focus on implementing HHS rules that address
the Administrative Simplification provisions of HIPAA. (See the
related discussion “The Health Insurance Portability and Ac-
countability Act of 1996” in the “Regulatory Developments” sec-
tion of this Alert.) This focus continues for many health care
organizations in 2003. Compliance with these rules requires a
multiyear effort with the potential for significant resource out-
lays, including major changes for processing. Noncompliance
with HIPAA Administrative Simplification provision rules can
subject affected health care organizations to civil and criminal
penalties. Also, health care organizations that are unable to com-
ply with the required deadlines for submission of electronic
claims in the HIPAA required format may find such claims re-
jected by third-party payers.
Health care organizations may have implemented, and may be
continuing to implement, system changes necessary to accommo-
date the Administrative Simplification provision rules. Auditors
should be alert for risks relevant to financial reporting that can
arise or change due to, for example, new systems or system
changes. SAS No. 55, Consideration of Internal Control in a Fi-
nancial Statement Audit (AICPA, Professional Standards, vol. 1,
12
2. Readers should refer to the full text of the laws, regulations, auditing and accounting
standards, and other pronouncements that are discussed in this section of the Alert.
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AU sec. 319), as amended, provides guidance on the independent
auditor’s consideration of an entity’s internal control in an audit
of financial statements in accordance with GAAS.
Auditors of a health care organization should consider their
client’s preparations for compliance with the HIPAA Administra-
tive Simplification provision rules and be alert for any conditions
or events that, when considered in the aggregate, indicate there
could be substantial doubt about the client’s ability to continue as
a going concern for a reasonable period of time not to exceed one
year beyond the date of the financial statements being audited.
The significance of such conditions and events will depend on the
circumstances, and some may have significance only when viewed
in conjunction with others, as discussed in SAS No. 59, The Audi-
tor’s Consideration of an Entity’s Ability to Continue as a Going Con-
cern (AICPA, Professional Standards, vol. 1, AU sec. 341).
Implementing regulations such as the rules issued to address the
HIPAA Administrative Simplification provisions may result in
increases in certain expense categories. The auditor should con-
sider this when designing and performing analytical procedures
in financial statement audits conducted in accordance with
GAAS. SAS No. 56, Analytical Procedures (AICPA, Professional
Standards, vol. 1, AU sec. 329), provides guidance on the use of
analytical procedures.
Also, the AICPA has published a question and answer (Q&A),
commonly referred to as a Technical Practice Aid (TPA),3 “Ac-
counting for Computer Systems Costs Incurred in Connection
With the Health Insurance Portability and Accountability Act of
1996” (AICPA, Technical Practice Aids, vol. 1, TIS sec. 6400.34),
to provide nonauthoritative guidance on accounting by health
care organizations for costs associated with upgrading and im-
proving computer systems to comply with HIPAA.
3. Section 6400 in the “Technical Questions and Answers” section of Technical Practice
Aids includes questions and answers (Q&As) specifically pertaining to health care or-
ganizations. The Q&As are nonauthoritative, and are based on selected practice mat-
ters identified by the staff of the AICPA Technical Hotline and various other bodies
within the AICPA.
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HHS published final rules with standards for privacy and security
of individually identifiable health information. Covered entities
are required to execute agreements with business associates to en-
sure the business associates protect the privacy of health informa-
tion. The new security standards will provide further requirements
for business associate contracts.
Auditors of health care organizations that are covered entities
may be considered business associates. Auditors should consider
the effect of the final rule and the rule’s business associates provi-
sions on the audit. For example, SAS No. 96, Audit Documenta-
tion (AICPA, Professional Standards, vol. 1, AU sec. 339), states
that the auditor should prepare and maintain audit documenta-
tion, the form and content of which should be designed to meet
the circumstances of the particular audit engagement. The quan-
tity, type, and content of audit documentation are matters of the
auditor’s professional judgment. If the health care organization
client refuses to share information with its auditor due to con-
cerns over violating privacy regulations, the auditor should con-
sider whether the inability to obtain information as a result of the
refusal by the client constitutes a scope limitation on the audit.
As discussed in SAS No. 58, Reports on Audited Financial State-
ments (AICPA, Professional Standards, vol. 1, AU sec. 508), as
amended, restrictions on the scope of the audit, whether imposed
by the client or by circumstances, such as the inability to obtain
sufficient competent evidential matter, may require the auditor to
qualify his or her opinion or to disclaim an opinion. In such in-
stances, the reasons for the auditor’s qualification of opinion or
disclaimer of opinion should be described in the report.
Prospective Payment System Audit Considerations
Prospective rate setting may result from a contractual agreement
with a third party, or be mandated through legislation. Recent
Alerts have discussed new Medicare PPS mandated by the passage
of the Balanced Budget Act of 1997. CMS (previously the Health
Care Finance Administration) issued a number of rules in recent
years establishing PPS for determining payments to health care
providers. Most recently, a PPS was established for long-term care
14
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hospitals. Under this PPS, long-term care hospitals are paid for
Medicare patients on a per discharge basis. A five-year transition
period was implemented to phase in this PPS. Other PPS estab-
lished in recent years include a home health care agency PPS and
an inpatient rehabilitation PPS.
The rules governing these regulatory PPS are complex and subject
to modification. A number of new CMS regulations and program
memos were published during 2003. (One of the more significant
of these, a final rule revising the methodology for determining
outlier payments to Medicare-participating hospitals, is discussed
in the “Regulatory Developments” section of this Alert.)
Modification of negotiated contracts with managed care compa-
nies, and changes to government payer PPS regulations, may
have a significant impact on a health care organization. The
health care organization’s full established rates may become sub-
ject to greater regulatory scrutiny. Personnel will require addi-
tional training. The health care organization may contract with a
third-party billing organization, implement new computer sys-
tems, or make significant changes to existing systems so that the
appropriate revenues can be calculated, processed, and billed. For
example, health care organizations providing home health care
agency services to Medicare patients under the PPS receive pay-
ments for 60-day episodes of care. Outlier payments are made for
beneficiaries whose resource needs are especially large.
These changes may be occurring at the same time the health care
organization is addressing other new regulatory requirements,
such as HIPAA Administrative Simplification Rules.
Where a negative financial impact as a result of a new PPS rule or
rule modification is especially significant, the affected health care
organization may choose to eliminate programs and services in
anticipation of, or in response to, adverse financial effects. If pro-
grams or services are not eliminated, the health care organization
may respond to anticipated declines in revenue with cost-cutting
measures. Auditors should consider the applicability of the guid-
ance in Financial Accounting Standards Board (FASB) Statement
of Financial Accounting Standards No. 146, Accounting for Costs
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Associated with Exit or Disposal Activities, for costs associated with
exit or disposal activities, including certain contract terminations.
FASB Statement No. 146 nullifies Emerging Issues Task Force
(EITF) Issue No. 94-3, Liability Recognition for Certain Employee
Termination Benefits and Other Costs to Exit an Activity (including
Certain Costs Incurred in a Restructuring).
Auditors of health care organizations should consider whether changes
to PPS regulations and contracts may create any incentive for clients to
look for inappropriate methods of maximizing income, and whether
management has adopted inappropriate revenue recognition policies.
Auditors may need to be attentive to warning signals that indicate in-
creased audit risk with respect to revenue recognition and respond
with appropriate professional skepticism. Auditors should consider the
guidance in SAS No. 47, Audit Risk and Materiality in Conducting an
Audit (AICPA, Professional Standards, vol. 1, AU sec. 312), as
amended, on the consideration of audit risk and materiality when
planning and performing an audit of financial statements. Also, State-
ment of Position (SOP) 00-1, Auditing Health Care Third-Party Rev-
enues and Related Receivables, provides guidance to auditors regarding
uncertainties inherent in health care third-party revenue recognition.
(See the related discussion “A Presumption That Improper Revenue
Recognition Is a Fraud Risk” in this section of the Alert).
Consideration of Fraud in a Financial Statement Audit
SAS No. 99, Consideration of Fraud in a Financial Statement Audit
(AICPA, Professional Standards, vol. 1, AU sec. 316), is the primary
source of authoritative guidance about an auditor’s responsibilities
concerning the consideration of fraud in a financial statement audit.
SAS No. 99 supersedes SAS No. 82, Consideration of Fraud in a Fi-
nancial Statement Audit (AICPA, Professional Standards, vol. 1, AU
sec. 316A), and amends SAS No. 1, Codification of Auditing Stan-
dards and Procedures (AICPA, Professional Standards, vol. 1, AU sec.
230, “Due Professional Care in the Performance of Work”). SAS
No. 99 establishes standards and provides guidance to auditors in
fulfilling their responsibility to plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free
of material misstatement, whether caused by error or fraud as stated
16
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in SAS No. 1, Codification of Auditing Standards and Procedures
(AICPA, Professional Standards, vol. 1, AU sec. 110.02, “Responsi-
bilities and Functions of the Independent Auditor”). SAS No. 99
also amends SAS No. 85, Management Representations (AICPA, Pro-
fessional Standards, vol. 1, AU sec. 333), as amended.
There are two types of misstatements relevant to the auditor’s
consideration of fraud in a financial statement audit:
• Misstatements arising from fraudulent financial reporting
• Misstatements arising from misappropriation of assets
Three conditions generally are present when fraud occurs. First,
management or other employees have an incentive or are under
pressure, which provides a reason to commit fraud. Second, cir-
cumstances exist—for example, the absence of controls, ineffective
controls, or the ability of management to override controls—that
provide an opportunity for a fraud to be perpetrated. Third, those
involved are able to rationalize committing a fraudulent act.
The Importance of Exercising Professional Skepticism
Because of the characteristics of fraud, the auditor’s exercise of
professional skepticism is important when considering the risk of
material misstatement due to fraud. Professional skepticism is an
attitude that includes a questioning mind and a critical assess-
ment of audit evidence. The auditor should conduct the engage-
ment with a mindset that recognizes the possibility that a
material misstatement due to fraud could be present, regardless of
any past experience with the entity and regardless of the auditor’s
belief about management’s honesty and integrity. Furthermore,
professional skepticism requires an ongoing questioning of
whether the information and evidence obtained suggests that a
material misstatement due to fraud has occurred.
Discussion Among Engagement Personnel Regarding the Risks
of Material Misstatement Due to Fraud
Members of the audit team should discuss the potential for mate-
rial misstatement due to fraud in accordance with the require-
ments of SAS No. 99 (AU sec. 316.14-.18). The discussion
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among the audit team members about the susceptibility of the
entity’s financial statements to material misstatement due to
fraud should include a consideration of the known external and
internal factors affecting the entity that might (a) create incen-
tives/pressures for management and others to commit fraud, (b)
provide the opportunity for fraud to be perpetrated, and (c) indi-
cate a culture or environment that enables management to ratio-
nalize committing fraud. Communication among the audit team
members about the risks of material misstatement due to fraud
also should continue throughout the audit.
See the Appendix to this Alert for additional discussion and ex-
amples of fraud risk factors for health care organizations, classi-
fied based on the three conditions generally present when
material misstatements due to fraud occur: (1) incentives/pres-
sures, (2) opportunities, and (3) attitudes/rationalizations.
Obtaining the Information Needed to Identify the Risks of
Material Misstatement Due to Fraud
SAS No. 22, Planning and Supervision (AICPA, Professional Stan-
dards, vol. 1, AU sec. 311.06–.08), provides guidance about how
the auditor obtains knowledge about the entity’s business and the
industry in which it operates. In performing that work, informa-
tion may come to the auditor’s attention that should be consid-
ered in identifying risks of material misstatement due to fraud. As
part of this work, the auditor should perform the following pro-
cedures to obtain information that is used (as described in SAS
No. 99 [AU sec. 316.35-.42]) to identify the risks of material
misstatement due to fraud:
1. Make inquiries of management and others within the en-
tity to obtain their views about the risks of fraud and how
they are addressed. (See SAS No. 99 [AU sec. 316.20-.27].)
2. Consider any unusual or unexpected relationships that
have been identified in performing analytical procedures in
planning the audit. (See SAS No. 99 [AU sec. 316.28-.30].)
3. Consider whether one or more fraud risk factors exist. (See
SAS No. 99 [AU sec. 316.31-.33] and the Appendix to
SAS No. 99.)
18
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4. Consider other information that may be helpful in the
identification of risks of material misstatement due to
fraud. (See SAS No. 99 [AU sec. 316.34].)
In planning the audit, the auditor also should perform analytical
procedures relating to revenue with the objective of identifying
unusual or unexpected relationships involving revenue accounts
that may indicate a material misstatement due to fraudulent fi-
nancial reporting.
Considering Fraud Risk Factors. The auditor may identify events
or conditions that indicate incentives/pressures to perpetrate
fraud, opportunities to carry out the fraud, or attitudes/rational-
izations to justify a fraudulent action. Such events or conditions
are referred to as “fraud risk factors.” Fraud risk factors do not
necessarily indicate the existence of fraud; however, they often are
present in circumstances where fraud exists.
SAS No. 99 provides fraud risk factor examples that have been
written to apply to most enterprises. The Appendix to this Alert
contains a list of fraud risk factors specific to health care organi-
zations. Remember that fraud risk factors are only one of several
sources of information an auditor considers when identifying and
assessing risk of material misstatement due to fraud.
Identifying Risks That May Result in a Material 
Misstatement Due to Fraud
In identifying risks of material misstatement due to fraud, it is
helpful for the auditor to consider the information that has been
gathered in accordance with the requirements of SAS No. 99 (AU
sec. 316.19-.34). The auditor’s identification of fraud risks may
be influenced by characteristics such as the size, complexity, and
ownership attributes of the entity. In addition, the auditor should
evaluate whether identified risks of material misstatement due to
fraud can be related to specific financial-statement account bal-
ances or classes of transactions and related assertions, or whether
they relate more pervasively to the financial statements as a
whole. Certain accounts, classes of transactions, and assertions
that have high inherent risk because they involve a high degree of
management judgment and subjectivity also may present risks of
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material misstatement due to fraud because they are susceptible
to manipulation by management.
A Presumption That Improper Revenue Recognition 
Is a Fraud Risk
Material misstatements due to fraudulent financial reporting
often result from an overstatement of revenues (for example,
through premature revenue recognition or recording fictitious
revenues) or an understatement of revenues (for example,
through improperly shifting revenues to a later period). There-
fore, the auditor should ordinarily presume that there is a risk of
material misstatement due to fraud relating to revenue recogni-
tion (see SAS No. 99 [AU sec. 316.41]). 
A Consideration of the Risk of Management 
Override of Controls
Even if specific risks of material misstatement due to fraud are
not identified by the auditor, there is a possibility that manage-
ment override of controls could occur, and accordingly, the audi-
tor should address that risk (see SAS No. 99 [AU sec. 316.57])
apart from any conclusions regarding the existence of more
specifically identifiable risks. Specifically, the procedures de-
scribed in SAS No. 99 (AU sec. 316.58-.67) should be performed
to further address the risk of management override of controls.
These procedures include (1) examining journal entries and other
adjustments for evidence of possible material misstatement due
to fraud, (2) reviewing accounting estimates for biases that could
result in material misstatement due to fraud, and (3) evaluating
the business rationale for significant unusual transactions.
Assessing the Identified Risks After Taking Into 
Account an Evaluation of the Entity’s Programs and 
Controls That Address the Risks
Auditors should comply with the requirements of SAS No. 99 (AU
sec. 316.43-.45) concerning an entity’s programs and controls that
address identified risks of material misstatement due to fraud.
The auditor should consider whether such programs and con-
trols mitigate the identified risks of material misstatement due
20
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to fraud or whether specific control deficiencies exacerbate the
risks. After the auditor has evaluated whether the entity’s pro-
grams and controls have been suitably designed and placed in
operation, the auditor should assess these risks taking into ac-
count that evaluation. The assessment should be considered
when developing the auditor’s response to the identified risks
of material misstatement due to fraud.
Responding to the Results of the Assessment
SAS No. 99 (AU sec. 316.46-.67) provides requirements and
guidance about an auditor’s response to the results of the assess-
ment of the risks of material misstatement due to fraud. The au-
ditor responds to risks of material misstatement due to fraud in
the following three ways:
1. A response that has an overall effect on how the audit is
conducted—that is, a response involving more general
considerations apart from the specific procedures other-
wise planned (see SAS No. 99 [AU sec. 316.50]).
2. A response to identified risks involving the nature, timing,
and extent of the auditing procedures to be performed (see
SAS No. 99 [AU sec. 316.51-.56]). Examples of auditing
procedures that could be performed by auditors of health
care organizations are provided in the Appendix to this Alert.
3. A response involving the performance of certain proce-
dures to further address the risk of material misstatement
due to fraud involving management override of controls,
given the unpredictable ways in which such override could
occur (see SAS No. 99 [AU sec. 316.57-.67]).
Evaluating Audit Evidence
SAS No. 99 (AU sec. 316.68-.78) provides requirements and guid-
ance for evaluating audit evidence. The auditor should evaluate
whether analytical procedures that were performed as substantive
tests or in the overall review stage of the audit indicate a previously
unrecognized risk of material misstatement due to fraud. The au-
ditor also should consider whether responses to inquiries through-
out the audit about analytical relationships have been vague or
ARA Health Care.qxd  12/23/2003  3:54 PM  Page 21
implausible, or have produced evidence that is inconsistent with
other evidential matter accumulated during the audit.
At or near the completion of fieldwork, the auditor should evalu-
ate whether the accumulated results of auditing procedures and
other observations affect the assessment of the risks of material
misstatement due to fraud made earlier in the audit. As part of
this evaluation, the auditor with final responsibility for the audit
should ascertain that there has been appropriate communication
with the other audit team members throughout the audit regard-
ing information or conditions indicative of risks of material mis-
statement due to fraud.
Responding to Misstatements That May Be the 
Result of Fraud
When audit test results identify misstatements in the financial
statements, the auditor should consider whether such misstate-
ments may be indicative of fraud. See SAS No. 99 (AU sec.
316.75-.78) for requirements and guidance about an auditor’s re-
sponse to misstatements that may be the result of fraud. If the au-
ditor believes that misstatements are or may be the result of
fraud, but the effect of the misstatements is not material to the fi-
nancial statements, the auditor nevertheless should evaluate the
implications, especially those dealing with the organizational po-
sition of the person(s) involved.
If the auditor believes that the misstatement is or may be the re-
sult of fraud, and either has determined that the effect could be
material to the financial statements or has been unable to evaluate
whether the effect is material, the auditor should:
1. Attempt to obtain additional evidential matter to deter-
mine whether material fraud has occurred or is likely to
have occurred, and, if so, its effect on the financial state-
ments and the auditor’s report thereon.4
4. See Statement on Auditing Standards (SAS) No. 58, Reports on Audited Financial
Statements (AICPA, Professional Standards, vol. 1, AU sec. 508), for guidance on au-
ditor’s reports issued in connection with audits of financial statements.
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2. Consider the implications for other aspects of the audit
(see SAS No. 99 [AU sec. 316.76]).
3. Discuss the matter and the approach for further investiga-
tion with an appropriate level of management that is at
least one level above those involved, and with senior man-
agement and the audit committee.5
4. If appropriate, suggest that the client consult with legal counsel.
The auditor’s consideration of the risks of material misstatement
and the results of audit tests may indicate such a significant risk of
material misstatement due to fraud that the auditor should consider
withdrawing from the engagement and communicating the reasons
for withdrawal to the audit committee or others with equivalent au-
thority and responsibility. The auditor may wish to consult with
legal counsel when considering withdrawal from an engagement.
Communicating About Possible Fraud to Management, the
Audit Committee, and Others
Whenever the auditor has determined that there is evidence that
fraud may exist, that matter should be brought to the attention of
an appropriate level of management. See SAS No. 99 (AU sec.
316.79-.82) for further requirements and guidance about com-
munications with management, the audit committee, and others.
Documenting the Auditor’s Consideration of Fraud
SAS No. 99 (AU sec. 316.83) requires certain items and events to
be documented by the auditor. Auditors should comply with
those requirements.
Practical Guidance
The AICPA Practice Aid Fraud Detection in a GAAS Audit—SAS
No. 99 Implementation Guide (product no. 006613kk) provides a
wealth of information and help on complying with the provisions
of SAS No. 99. Moreover, this Practice Aid provides an under-
standing of the differences between the requirements of SAS No. 99
5. If the auditor believes senior management may be involved, discussion of the matter
directly with the audit committee may be appropriate.
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and SAS No. 82, which was superseded by SAS No. 99. This
Practice Aid is an Other Auditing Publication as defined in SAS
No. 95, Generally Accepted Auditing Standards (AICPA, Profes-
sional Standards, vol. 1, AU sec. 150). Other Auditing Publica-
tions have no authoritative status; however, they may help the
auditor understand and apply SASs.
Help Desk—The AICPA’s Antifraud Resource Center at
www.aicpa.org/antifraud, on AICPA Online, is an online re-
source providing comprehensive tools, information, and re-
sources devoted to the prevention, detection, and investigation
of fraud.
2003 Audit and Accounting Guide Health Care Organizations
The Audit and Accounting Guide Health Care Organizations
(product no. 012613kk) was updated with conforming changes
as of January 1, 2003, to reflect the issuance of authoritative pro-
nouncements.
Among the conforming changes to the January 1, 2003, edition
of the Guide are updates for accounting pronouncements FASB
Statement No. 141, Business Combinations, FASB Statement No.
142, Goodwill and Other Intangible Assets, and FASB Statement
No. 144, Accounting for the Impairment or Disposal of Long-Lived
Assets. Conforming changes for the issuance of FASB Statement
No. 144 include modifications to Chapter 11 of the Guide to
eliminate the exception to consolidation for a temporarily con-
trolled subsidiary in circumstances in which the Guide required
consolidation based on a controlling financial interest.
Updates to the Guide for auditing pronouncements include con-
forming changes for SAS No. 92, Auditing Derivative Instru-
ments, Hedging Activities, and Investments in Securities (AICPA,
Professional Standards, vol. 1, AU sec. 332), and SAS No. 94, The
Effect of Information Technology on the Auditor’s Consideration of
Internal Control in a Financial Statement Audit (AICPA, Profes-
sional Standards, vol. 1, AU sec. 319).
Conforming changes were also made for the issuance of Govern-
mental Accounting Standards Board (GASB) Statement No. 34,
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Basic Financial Statements—and Management’s Discussion and
Analysis—for State and Local Governments, and related pro-
nouncements. Because of the phased-in effective dates of GASB
Statement No. 34, the conforming changes do not modify the
chapters and illustrative financial statements for a governmental
hospital authority in Appendix A to the Guide. A new Appendix
F was added to the Guide to discuss the requirements of GASB
Statement No. 34 and related pronouncements concerning gov-
ernmental health care entities that are included in the scope of
the Guide.
As discussed in paragraph 6 of new Appendix F, the Audit and
Accounting Guide Health Care Organizations is not the only in-
dustry-specific AICPA Audit and Accounting Guide that audi-
tors might have to consider when performing an audit of a
governmental health care entity. The Audit and Accounting
Guide Audits of State and Local Governments (GASB 34 Edition)
(product no. 012663kk) includes governmental health care enti-
ties in its scope and was cleared by the GASB. Therefore, certain
accounting and financial reporting guidance in that Guide con-
stitutes category (b) guidance for governmental health care enti-
ties, and auditing guidance in that Guide should also be
considered during an audit of a governmental health care entity
that is included in the scope of the Audit and Accounting Guide
Health Care Organizations.
Collectibility of Receivables
Health care organizations may see increases in the level of health
care services provided to uninsured patients. Tens of millions in
the United States are without health insurance coverage. Also, a
number of employers have passed on a greater share of their rising
health care benefit costs to employees. These employees, finding
increases prohibitive, may opt to forgo coverage or reduce their
level of coverage. Patient receivable collections may be negatively
affected for health care organizations operating in regions experi-
encing significant, long-term employee layoffs.
In some instances, patients who are uninsured and not designated
as charity care have been billed at rates that are significantly
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higher than amounts billed to insured patients. These higher bills
and the debt collection process have been in the media spotlight
in 2003. This issue has also received the attention of the House
Committee on Energy and Commerce. As a result of this
scrutiny, health care organizations may be reevaluating their poli-
cies and procedures for setting charges to self-pay patients, and
billing and collecting related receivables. Health care organiza-
tions may need to obtain appropriate regulatory approval of pro-
posed changes.
When auditing receivables, specific auditing objectives include
determining that amounts reported in the financial statements
represent valid receivables and do not include receivables for
charity care. Health care organizations establish their own criteria
for charity care, and must determine whether the individual pa-
tient meets the criteria. The policy for providing charity care and
the level of charity care provided should be disclosed.
The client’s estimate of the level of accounts receivable that may
not be collectible as a result of bad debts is reflected in the al-
lowance for doubtful accounts, which is one of the offsets used to
report receivables at their net realizable value. When auditing es-
timates, auditors should be familiar with SAS No. 57, Auditing
Accounting Estimates (AICPA, Professional Standards, vol. 1, AU
sec. 342), which provides guidance on obtaining and evaluating
sufficient competent evidential matter to support significant ac-
counting estimates used in a client’s financial statements. The
guidelines set forth by SAS No. 57 include the following:
• Identify the circumstances that require accounting estimates.
• Consider internal control relating to developing account-
ing estimates.
• Evaluate the reasonableness of management’s estimate.
As part of evaluating reasonableness, the auditor should obtain an
understanding of how management developed the estimate for
the allowance for doubtful accounts and, based on that under-
standing, use one or a combination of the following approaches
listed in SAS No. 57:
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• Review and test the process used by management to de-
velop the estimate.
• Develop an independent expectation of the estimate to
corroborate the reasonableness of management’s estimate.
• Review subsequent events or transactions occurring prior
to completion of fieldwork, including chargebacks from
credit card companies.
A review of the aging of receivables is often performed. This may
include testing the reliability of the aging report; reviewing past
due accounts on the report, including the number and amount of
such accounts; reviewing past due balances, the client’s prior his-
tory in collecting past due balances, and patient correspondence
files; and so forth. This may be done with the assistance of the
client in obtaining an understanding of how the allowance was
developed and determining whether it is reasonable. Testing the
reasonableness of the health care organization’s estimate of the
collectibility of receivables may also be performed by other proce-
dures, such as tests of subsequent collections.
Another tool in evaluating the allowance for doubtful accounts is
the application of analytical procedures. According to SAS No.
56, Analytical Procedures (AICPA, Professional Standards, vol. 1,
AU sec. 329.02), analytical procedures are an important part of
the audit process and consist of evaluations of financial informa-
tion made by a study of plausible relationships among both fi-
nancial and nonfinancial data. Often, the large number of
customer accounts makes it difficult to determine the adequacy
of the allowance only by reference to individual accounts, making
analytical procedures helpful to the audit process.
The auditor may also review revenue and receivables transactions
and fluctuations after the balance sheet date for items such as
writeoffs. This may provide additional information about the col-
lectibility of receivables and the reasonableness of the allowance
account on the balance sheet date.
See a related discussion in the Appendix to this Alert, “Health
Care Industry-Specific Conditions That May Indicate the Pres-
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ence of Fraud.” That discussion presents procedures related to the
allowance for uncollectible accounts that may be performed in re-
sponse to fraud risk factors. Also see Exhibit 5.1, “Auditing Con-
siderations” in the Audit and Accounting Guide Health Care
Organizations for examples of specific auditing objectives, selected
control activities, and auditing procedures that may be considered
when auditing the major components of receivables, including the
allowance for doubtful accounts, and contractual adjustments.
Malpractice Losses
This section of the Alert spotlights auditing issues and accounting
guidance for malpractice losses. As discussed in the “Economic
and Industry Developments” section of this Alert, increases in
medical malpractice costs were in the spotlight in 2003, getting
the attention of politicians and patients in addition to providers of
health care services. In response, health care organizations may be
reevaluating their insurance coverage, opting to increase de-
ductibles or increase the extent of risk retained as a result of
changes in policy terms. Other responses may include changes in
actuaries or assumptions to determine malpractice losses.
The existence of an insurance policy, by itself, is no assurance that
the risk of financial loss is transferred. The extent of risk transfer is
key in determining whether a liability should be recognized. If the
health care organization has not transferred risk to an external third
party, the organization should evaluate its exposure to losses that
arise from malpractice claims and record a liability, if appropriate.
The ultimate costs of malpractice claims, which include costs associ-
ated with litigating or settling claims, are accrued when the incidents
that give rise to the claims occur. Estimated losses from asserted and
unasserted claims are accrued either individually or on a group basis,
based on the best estimates of the ultimate costs of the claims and the
relationship of past reported incidents to eventual claims payments.
When auditing medical malpractice loss contingencies, auditors
should review insurance contracts and determine the extent of
risk retained by the health care organization. Once the extent of
risk retained is determined, the nature, extent, and timing of
other auditing procedures can be determined.
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If the health care organization retains all or a portion of the risk with
self-insurance, or through purchase of a claims-made policy, the au-
ditor should perform additional auditing procedures to obtain rea-
sonable assurance that the organization’s accounting for medical
malpractice losses is in accordance with generally accepted account-
ing principles (GAAP). See the related discussion “Claims-Made In-
surance Coverage” in the “Accounting Issues and Developments”
section of this Alert. Additional guidance about liabilities recognized
pertaining to medical malpractice claims is provided in Chapter 8 of
the Audit and Accounting Guide Health Care Organizations.
If losses relating to a particular category of malpractice claims can-
not be estimated, the potential losses related to that category of
claims are not to be accrued and the contingency is disclosed in
the notes to the financial statements, as required by FASB State-
ment No. 5, Accounting for Contingencies. The Guide provides other
financial statement disclosures required for malpractice liabilities:
• The program of medical malpractice insurance coverages
and the basis for any related loss accruals.
• The carrying amount of accrued malpractice claims that
are discounted in the financial statements and the interest
rate or rates used to discount claims.
As discussed in paragraph 8.37 of the Guide, an accrual for malprac-
tice losses should be based on estimated ultimate losses and costs as-
sociated with settling claims. Accruals should not be based on
recommended funding amounts, which in addition to a provision
for the actuarially determined liability, also includes a provision for
(a) credit for investment income and (b) a margin for risk of adverse
deviation. Paragraph 8.37 provides examples of factors to consider
and adjustments that may be required to convert actuarially deter-
mined malpractice funding amounts to an appropriate loss accrual
to be reported in the financial statements. 
If an actuary is involved in a substantial way in determining the
amount of a malpractice self-insurance liability, the auditor should
follow the requirements of SAS No. 73, Using the Work of a Specialist
(AICPA, Professional Standards, vol. 1, AU sec. 336). Additional
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guidance regarding the use of actuaries and actuarial methods can be
found in paragraphs 8.35 through 8.38 of the Guide.
When auditing malpractice losses, auditors should also consider
the guidance regarding auditing estimates found in SAS No. 57.
Also, see Exhibit 8.1, “Auditing Considerations,” in the Guide
for examples of specific auditing objectives, selected control activ-
ities, and auditing procedures that may be considered when au-
diting malpractice loss contingencies.
Pension Discount Assumptions
Compensation and benefit costs, including pension benefit costs,
can be significant to the financial statements of health care orga-
nizations. Health care organizations make a number of assump-
tions to determine pension expense and obligations, including
the interest rate used to determine the present value of liabilities
(discount rate) and the expected rate of return on plan assets.
Auditors should consider with an attitude of professional skepti-
cism the objective and subjective factors used by management in
setting the discount rate and other assumptions used by manage-
ment to estimate obligations and expenses under pension benefit
plans. Guidance on auditing estimates is found in SAS No. 57.
Auditors should also consider the disclosure requirements in SOP
94-6, Disclosure of Certain Significant Risks and Uncertainties.
Also, your health care organization clients may be recording a minimum
pension liability. As a reminder, paragraph 10.186 of the Audit and Ac-
counting Guide Health Care Organizations provides guidance on items
that should be reported separately from the performance indicator in the
statement of operations of not-for-profit health care organizations. These
items include other items that are required by GAAP to be reported sep-
arately, such as minimum pension liabilities in accordance with para-
graph 37 of FASB Statement No. 87, Employers’ Accounting for Pensions.
6. See the related discussion “SOP 02-2, Accounting for Derivative Instruments and Hedging
Activities by Not-for-Profit Health Care Organizations, and Clarification of the Perfor-
mance Indicator” in the “New Accounting Pronouncements and Other Guidance” sec-
tion of this Alert. Also, the Financial Accounting Standards Board (FASB) has on its
agenda a project to develop improved disclosures related to pension plans. See the FASB
Web site at www.fasb.org for information about this project.
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Auditing Valuations of Investee Financial Results
If your health care organization clients’ investments include part-
nerships or limited liability companies, and GAAP requires the
valuation of these investments in your client’s financial state-
ments based on the investee’s financial results, you will find guid-
ance in SAS No. 92, Auditing Derivative Instruments, Hedging
Activities, and Investments in Securities, which can assist in audit-
ing valuations of these investments.
For valuations based on an investee’s financial results, including but
not limited to the equity method of accounting, the investor’s au-
ditor should obtain sufficient evidence in support of the investee’s
financial results. The investor’s auditor should read available finan-
cial statements of the investee and the accompanying audit report,
if any. If the accompanying audit report is satisfactory, the financial
statements of the investee may constitute sufficient evidential mat-
ter. Footnote 14 to paragraph 28 of SAS No. 92 discusses proce-
dures that can be performed to determine if the report of another
auditor is satisfactory. If the investee’s financial statements are not
audited, or if the investee auditor’s report is not satisfactory to the
investor’s auditor for this purpose, the investor’s auditor should
apply, or request that the investor arrange with the investee to have
another auditor apply, appropriate auditing procedures to the fi-
nancial statements, considering the materiality of the investment.
If in the auditor’s judgment additional evidential matter is
needed, for example, because of significant differences in the in-
vestor and investee fiscal year-ends, the auditor should perform
procedures to gather such evidence.
SAS No. 92 provides guidance on other matters to consider when
auditing valuations based on an investee’s financial results, such
as a time lag in reporting between the date of the financial state-
ments of the investor and the investee, and subsequent events.
Restriction on Distribution of Obligated Group 
Financial Statements
Obligated group is a term used to denote a group of entities,
sometimes a parent corporation and several of its subsidiaries,
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that is liable for the repayment of an obligation, such as tax-ex-
empt bonds. Compliance with loan or other agreements may re-
quire preparation of obligated group financial statements that
exclude entities that are required to be consolidated by GAAP.
Auditors should consider the guidance in SAS No. 62, Special Re-
ports (AICPA, Professional Standards, vol. 1, AU sec. 623), for re-
porting guidance when this form of financial statement
presentation is prescribed. Additional reporting guidance is pro-
vided in the Audit and Accounting Guide Health Care Organiza-
tions, paragraph 12.06, and Exhibit 12-4, “Report on Financial
Statements Prepared Pursuant to a Master Trust Indenture That
Results in a Presentation Not in Conformity With Generally Ac-
cepted Accounting Principles or Other Comprehensive Basis of
Accounting.” Auditors should be aware that where obligated
group financial statements exclude entities that are required
under GAAP to be consolidated in order to comply with loan
agreements, the accountant’s report should restrict the use to
specified parties (see Exhibit 12-4). Use should be restricted to
the company and other parties to the agreement.
Continuing Disclosures
In a November 1994 amendment to Rule 15c2-12, the SEC re-
quired municipal securities dealers to contract with issuers of mu-
nicipal bonds for them to provide continuing disclosures at
certain times for the life of the bond issue. Continuing disclo-
sures, or secondary market disclosure requirements, are made by
issuers providing to nationally recognized municipal securities in-
formation repositories (NRMSIRs) and state information reposi-
tories annual continuing disclosure documents and material
events notices.
Note: The Office of Municipal Securities of the SEC has re-
leased “Tips for Making Continuing Disclosure Filings,” avail-
able on the SEC Web site at www.sec.gov.
Last year, the SEC Office of Municipal Securities studied the sys-
tem of NRMSIRs. The study found that municipal securities is-
suers and conduit borrowers frequently are not filing their
contractually required annual continuing disclosures. Issuers and
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conduit borrowers frequently fail to make the required filings be-
cause they are not aware of their obligation or the potential con-
sequences of noncompliance. Such potential consequences are (1)
broker-dealers may become unable to recommend the purchase
of the entity’s securities, reducing their liquidity, and (2) issuers
and conduit borrowers must disclose their failures to file in the
offering document for their next bond issue. If an issuer or con-
duit borrower repeatedly fails to meet its obligation to file in a
timely manner, broker-dealers may be unable to underwrite or
bid for the offering.
You should also be aware of the increasing need for municipal se-
curities issuers and conduit borrowers to have their financial
statements produced in an electronic format. Issuers and conduit
borrowers are increasing their use of the Internet to disseminate
information, including financial statements. Further, the Munic-
ipal Council, a group of 20 organizations representing all sectors
of the municipal market, is developing a central electronic filing
location (commonly referred to as an electronic post office) that
would accept electronic filings from issuers and conduit borrow-
ers and simultaneously forward each filing to every NRMSIR.
This post office may become operational in 2004.
Paragraph 16.09 in the Audit and Accounting Guide Audits of
State and Local Governments (GASB 34 Edition) states that the au-
ditor is not required to participate in, or undertake any proce-
dures with respect to, a government’s continuing disclosure
documents, even though they may include audited financial
statements. A government’s continuing disclosures are not re-
quired to be submitted to or disseminated from the distributing
organizations as a single document. Thus, an auditor’s association
with other information encompassed by such disclosures cannot
be clearly established. Therefore, the provisions of SAS No. 8,
Other Information in Documents Containing Audited Financial
Statements (AICPA, Professional Standards, vol. 1, AU sec. 550),
as amended, do not apply to documents that contain those dis-
closures. Any attention the auditor devotes to other information
included with audited financial statements in continuing disclo-
sure documents at the government’s request should be considered
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a consulting engagement under the provisions of the AICPA
Statement on Standards for Consulting Services No. 1, Consult-
ing Services: Definitions and Standards (AICPA, Professional Stan-
dards, vol. 2, CS sec. 100).
An auditor may become aware during a financial statement audit
that a health care organization has not complied with its continu-
ing disclosure obligations. In such situations, the auditor may
want to assess the entity’s internal control over making the re-
quired filings and report deficiencies in that internal control in
the management letter. For health care organizations that follow
GASB standards, such noncompliance may also have a material
indirect effect on the financial statements, and the auditor should
consider the adequacy of the governmental health care organiza-
tion’s financial statement disclosure about the violations and the
actions taken to address them, as well as the effect of nondisclo-
sure on the auditor’s report.
Recent Revision to AICPA Ethics Interpretation
Regarding Governmental Entities
The AICPA Professional Ethics Executive Committee revised
Ethics Interpretation 101-10, “The Effect on Independence of
Relationships With Entities Included in the Governmental Fi-
nancial Statements,” of ET section 101, Independence (AICPA,
Professional Standards, vol. 2, ET sec. 101.12).
Ethics Interpretation 101-10 discusses the effect on an auditor’s
independence of relationships with entities included in govern-
mental financial statements. The revision, effective March 2003,
reflects new wording related to changes resulting from issuance of
GASB Statement No. 34. In addition, certain changes were made
to the Interpretation to conform it to the AICPA’s new indepen-
dence rules that were issued in November 2001 (that is, engage-
ment-team focused approach to independence). Finally, the
revision changes the focus of the Interpretation, which had been
based on the commercial model concept of financial control, to an
accountability focus, which is more consistent with the govern-
ment reporting model.
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Help Desk—You can find the revision to Ethics Interpretation
101-10 in the March 2003 issue of the Journal of Accountancy.
For a list of all recent revisions and other changes to AICPA
ethics interpretations and rulings, including revisions to Interpre-
tation 101-3, “Performance of Other Services,” of ET section
101, Independence (AICPA, Professional Standards, vol. 2, ET sec.
101.05), and for a discussion of professional ethics and indepen-
dence developments, see the AICPA Independence and Ethics
Audit Risk Alert—2003/04 (product no. 022474kk).
New Auditing and Attestation Pronouncements and 
Other Guidance
Presented below is a list of auditing and attestation pronounce-
ments, guides, and other guidance issued since the writing of last
year’s Alert. The AICPA general Audit Risk Alert—2003/04
(product no. 022334kk) contains a summary explanation of all
these issuances. The PCAOB sets standards for audits of public
companies. See the PCAOB Web site at www.pcaobus.org for in-
formation about PCAOB activities and any standards issued by
the PCAOB. For information on auditing and attestation stan-
dards issued subsequent to the writing of this Alert, please refer to
AICPA Online at www.aicpa.org/members/div/auditstd/tech-
nic.htm and to the PCAOB Web site. You may also look for an-
nouncements of newly issued standards in the CPA Letter, the
Journal of Accountancy, and the quarterly electronic newsletter, In
Our Opinion, issued by the AICPA Auditing Standards Team and
available at www.aicpa.org.
SAS No. 101 Auditing Fair Value Measurements and Disclosures
Issued in January 2003. This SAS is effective for audits of 
financial statements for periods beginning on or after 
June 15, 2003. Earlier application is permitted.
Audit Interpretation Interpretation No. 16, “Effect on Auditor’s Report of 
of SAS No. 58, Omission of Schedule of Investments by Investment 
Reports on Audited Partnerships That Are Exempt From Securities and
Financial Statements Exchange Commission Registration Under the 
Investment Company Act of 1940” 
Published in the June 2003 Journal of Accountancy.
(continued)
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Audit Interpretation  Amendment of Interpretation No. 2, “The Effect of an
of SAS No. 31, Inability to Obtain Evidential Matter Relating to 
Evidential Matter Income Tax Accruals”
Published in the June 2003 Journal of Accountancy.
Audit Guide Audits of States, Local Governments, and Not-for-Profit 
Organizations Receiving Federal Awards (with conforming 
changes as of May 1, 2003)
This Audit Guide is the former SOP 98-3, Audits of 
States, Local Governments, and Not-for-Profit 
Organizations Receiving Federal Awards.
Attestation Interpretation No. 5, “Attest Engagements on
Interpretation Financial Information Included in XBRL
of Statement on Instance Documents”
Standards for Published in the November 2003 Journal of Accountancy.
Attestation 
Engagements 




(not applicable to 
attest engagements 
on public companies)
SOP No. 03-2 Attest Engagements on Greenhouse Gas
(not applicable to Emissions Information
attest engagements Issued in September 2003. This SOP is effective for
on public companies) reports on attest engagements on greenhouse gas emissions
information issued on or after December 15, 2003. 
Early implementation is permitted.
Practice Alert Audit Confirmations
No. 2003-1
(nonauthoritative)
Practice Alert Journal Entries and Other Adjustments
No. 2003-2
(nonauthoritative)
Toolkit Auditing Fair Value Measurements and Disclosures: 
(nonauthoritative) Allocations of the Purchase Price Under FASB Statement 
of Financial Accounting Standards No. 141, Business 
Combinations, and Tests of Impairment Under FASB 
Statements No. 142, Goodwill and Other Intangible 
Assets, and No. 144, Accounting for the Impairment or 
Disposal of Long-Lived Assets
PCAOB Rule 3100T All registered public accounting firms are required to 
(applicable to public adhere to the PCAOB’s auditing and related professional 
company audits only) practice standards in connection with the preparation or 
issuance of any audit report for an issuer and in their 
auditing and related attestation practices.
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PCAOB Rule 3200T In connection with the preparation or issuance
(applicable to public of any audit report, a registered public accounting firm,
company audits only) and its associated persons, shall comply with GAAS, as 
described in SAS No. 95, as in existence on April 16, 2003.
PCAOB Rule 3300T In connection with an engagement (a) described in the 
(applicable to public AICPA’s Auditing Standards Board’s (ASB’s) SSAE No. 10 
company audits only) and (b) related to the preparation or issuance of audit 
reports for issuers, a registered public accounting firm, 
and its associated persons, shall comply with the SSAEs, 
and  related interpretations and SOPs, as in existence on 
April 16, 2003.
PCAOB Rule 3400T A registered public accounting firm, and its associated 
(applicable to public persons, shall comply with quality control standards,
company audits only) as described in (a) the AICPA ASB’s Statements on 
Quality Control Standards, as in existence on April 16, 
2003, and (b) the AICPA SEC Practice Section’s 
Requirements of Membership (d), (f ) (first sentence), 
(l), (m), (n)(1) and (o), as in existence on April 16, 2003.
Of the pronouncements, guides, and other guidance listed above,
those having particular significance to the health care industry are
briefly explained below. These summaries are for informational
purposes only and should not be relied upon as a substitute for a
complete reading of the applicable standard. To obtain copies of
AICPA standards and guides, contact the Member Satisfaction
Center at (888) 777-7077 or go online at www.cpa2biz.com.
Audit Guide for Performing OMB Circular A-133 Audits
In 2003, the AICPA issued the Audit Guide Audits of States, Local
Governments, and Not-for-Profit Organizations Receiving Federal
Awards, with conforming changes as of May 1, 2003 (product no.
012743kk). The ASB decided to convert SOP 98-3, Audits of
States, Local Governments, and Not-for-Profit Organizations Re-
ceiving Federal Awards, into an AICPA Audit Guide because the
content and guidance in the SOP are more similar to that which
would be included in an Audit Guide and also to make it more
clear that, like other AICPA Audit Guides, it is updated each year
for conforming changes. This Audit Guide does not supersede
the guidance that appeared in SOP 98-3 but rather changes its
format from an SOP to an Audit Guide. It is now one of the
AICPA’s primary sources of authoritative guidance for perform-
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ing audits under the Single Audit Act Amendments of 1996; U.S.
Office of Management and Budget (OMB) Circular A-133, Au-
dits of States, Local Governments, and Not-for-Profit Organizations;
and Government Auditing Standards.
SOP 98-3 has been removed from the AICPA publication Tech-
nical Practice Aids and as an appendix to the Audit and Account-
ing Guides Audits of State and Local Governmental Units
(Non-GASB 34 Edition), Audits of States and Local Governments
(GASB 34 Edition), and Not-for-Profit Organizations.
New Accounting Pronouncements and Other Guidance7
AICPA and FASB Pronouncements
Presented below is a list of accounting pronouncements and
other guidance issued since the writing of last year’s Alert. The
AICPA general Audit Risk Alert—2003/04 (product no.
022334kk) contains a summary explanation of all these is-
suances. These summaries are for informational purposes only
and should not be relied upon as a substitute for a complete read-
ing of the applicable standard. For information on accounting
standards issued subsequent to the writing of this Alert, please
refer to AICPA Online at www.aicpa.org and the FASB Web site
at www.fasb.org. You may also look for announcements of newly
issued standards in the CPA Letter and Journal of Accountancy.
FASB Statement Accounting for Stock-Based Compensation—
No. 148 Transition and Disclosure
Issued in December 2002. See paragraphs 4 and 5 of the 
Statement for effective date information.
FASB Statement Amendment of Statement 133 on Derivative Instruments
No. 149 and Hedging Activities
Issued in April 2003. This Statement is effective for contracts
entered into or modified after June 30, 2003. This Statement
is effective for hedging relationships designated after 
June 30, 2003. See paragraphs 39 and 40 of the Statement 
for additional effective date and transition information.
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7. The brief summaries of the accounting pronouncements discussed in this section of
the Alert are for informational purposes only and should not be relied upon as a sub-
stitute for a complete reading of the applicable standard.
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FASB Statement Accounting for Certain Financial Instruments with
No. 150 Characteristics of both Liabilities and Equity
Issued in May 2003. Most of the guidance in this 
Statement is effective for all financial instruments entered 
into or modified after May 31, 2003, and otherwise is 
effective at the beginning of the first interim period 
beginning after June 15, 2003. See paragraphs 29 through 
31 of the Statement for additional effective date and
transition information, including effective date information
for mandatorily redeemable financial instruments of a 
nonpublic entity. See FASB Staff Position (FSP)8 No. 
FAS 150-3, Effective Date, Disclosures, and Transition for 
Mandatorily Redeemable Financial Instruments of Certain 
Nonpublic Entities and Certain Mandatorily Redeemable 
Noncontrolling Interests under FASB Statement No. 150, 
Accounting for Certain Financial Instruments with 
Characteristics of both Liabilities and Equity, issued 
November 7, 2003, for additional effective date information.
FASB Interpretation Consolidation of Variable Interest Entities
(FIN) No. 46 Issued in January 2003. See paragraphs 26 through 29 of 
the Interpretation for effective date and transition information.
See FSP No. FIN 46-4, Transition Requirements for Initial
Application of FASB Interpretation No. 46, Consolidation 
of Variable Interest Entities, and FSP No. FIN 46-6, 
Effective Date of FASB Interpretation No. 46, Consolidation 
of Variable Interest Entities, for additional effective date 
and transition information.
SOP 02-2 Accounting for Derivative Instruments and Hedging 
Activities by Not-for-Profit Health Care Organizations, 
and Clarification of the Performance Indicator
Issued in December 2002. The provisions of this SOP are 
effective for fiscal years beginning after June 15, 2003. 
Earlier application is encouraged, but permitted only as of 
the beginning of any fiscal quarter that begins after issuance 
of this SOP. See paragraphs 10 and 11 of the SOP for 
additional effective date and transition information.
(continued)
8. Beginning in February 2003, the FASB staff introduced the FASB Staff Position (FSP) to
issue application guidance (like that found in Staff Implementation Guides and Staff An-
nouncements). A final FSP is announced in Action Alert and posted to the FASB Web
site at www.fasb.org, where it remains until incorporated into printed FASB literature.
The guidance contained in an FSP is effective for new transactions or arrangements en-
tered into after the beginning of the first fiscal quarter following the date that the final,
Board-cleared FSP is posted to the FASB Web site. If the effective date of a recently is-
sued pronouncement that is the subject of an FSP has not yet passed, then the guidance
in the FSP should be incorporated into the adoption of the new pronouncement.
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SOP 03-1 Accounting and Reporting by Insurance Enterprises for 
Certain Nontraditional Long-Duration Contracts and 
for Separate Accounts
Issued in July 2003. The provisions of this SOP are 
effective for financial statements for fiscal years beginning 
after December 15, 2003, with earlier adoption encouraged.
Technical Software Revenue Recognition
Practice Aids Released in February 2003.
(nonauthoritative)
Of the pronouncements and other guidance listed above, those
having particular significance to the health care industry are
briefly explained below. These summaries are for informational
purposes only and should not be relied upon as a substitute for a
complete reading of the applicable standard. To obtain copies of
AICPA standards and guides, contact the Member Satisfaction
Center at (888) 777-7077 or go online at www.cpa2biz.com.
SOP 02-2, Accounting for Derivative Instruments and Hedging
Activities by Not-for-Profit Health Care Organizations, and
Clarification of the Performance Indicator
SOP 02-2, Accounting for Derivative Instruments and Hedging Ac-
tivities by Not-for-Profit Health Care Organizations, and Clarifica-
tion of the Performance Indicator, amends the Audit and
Accounting Guide Health Care Organizations to address how
nongovernmental not-for-profit health care organizations should
report gains or losses on hedging and nonhedging derivative in-
struments under FASB Statement No. 133, Accounting for Deriv-
ative Instruments and Hedging Activities, as amended. SOP 02-2
requires that not-for-profit health care organizations should:
• Apply the provisions of FASB Statement No. 133 (including
the provisions pertaining to cash flow hedge accounting) in
the same manner as for-profit enterprises. Gain or loss items
that affect income from continuing operations of a for-profit
enterprise should affect a not-for-profit health care organiza-
tion’s performance indicator. Similarly, gain or loss items
that are excluded from a for-profit enterprise’s income from
continuing operations should be excluded from a not-for-
profit health care organization’s performance indicator.
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• Provide all of the disclosures required by paragraph 45 of
FASB Statement No. 133, including disclosures related to
reclassifications into earnings of gains and losses that are re-
ported in accumulated other comprehensive income. Al-
though not-for-profit health care organizations are not
otherwise required to report changes in the components of
comprehensive income pursuant to paragraph 26 of FASB
Statement No. 130, Reporting Comprehensive Income, such
organizations should separately disclose the beginning and
ending accumulated derivative gain or loss that has been ex-
cluded from the performance indicator (earnings measure),
the related net change associated with current period hedg-
ing transactions, and the net amount of any reclassifications
into the performance indicator in a manner similar to that
described in paragraph 47 of FASB Statement No. 133.
SOP 02-2 also amends paragraphs 10.17 and 10.18 of the Audit
and Accounting Guide Health Care Organizations to clarify that
the performance indicator (earnings measure) reported by not-
for-profit health care organizations is analogous to income from
continuing operations of a for-profit enterprise.
SOP 02-2 applies to not-for-profit health care organizations that
are within the scope of the Audit and Accounting Guide Health
Care Organizations, and does not apply to governmental entities
that are within the scope of the Guide.
SOP 02-2 should be applied prospectively for all contracts exist-
ing on the initial date of application of SOP 02-2 and for trans-
actions after that date. Derivative gains or losses reported in a
manner inconsistent with the provisions of SOP 02-2 in financial
statements for periods prior to the initial date of application of
SOP 02-2 should not be reclassified upon adoption. Any deriva-
tive gains and losses excluded from the performance indicator in
the financial statements issued for periods ended before the initial
date of application of SOP 02-2 that did not meet the cash flow
hedging criteria of FASB Statement No. 133 should not be re-
classified and included as a component of the performance indi-
cator in any period subsequent to the initial date of application of
SOP 02-2. The derivative gains and losses referred to in the pre-
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ceding sentence should not be included in the disclosure of the
accumulated derivative gain or loss (as described in paragraph 8
of SOP 02-2). However, to the extent that derivative gains or
losses on cash flow hedges qualifying under FASB Statement No.
133 had been reported in a manner consistent with the provisions
of SOP 02-2 in financial statements for periods prior to the ini-
tial date of application of SOP 02-2, such amounts should be in-
cluded in that disclosure and should be reclassified and included
in the performance indicator when the hedged transaction affects
the performance indicator.
When the financial statements of the year of adoption are pre-
sented separately or included in comparative financial statements,
the notes to the financial statements should disclose:
1. The fact that SOP 02-2 has been adopted and the effective
date of adoption (for example, beginning of a year or be-
ginning of a quarter).
2. The nature of any differences in accounting principles or
financial statement presentation applicable to the financial
statements presented that resulted from adoption of SOP
02-2 (for example: “The effective portion of unrealized
gains and losses on cash flow hedges, which prior to adop-
tion of SOP 02-2 were included in the performance indi-
cator, are now reported below the performance indicator”).
Disclosure of pro forma amounts is not required.
Paragraph 11 of SOP 02-2 reminds entities initially applying
hedge accounting upon adoption of SOP 02-2 that all the hedge
accounting criteria in FASB Statement No. 133 must be met for
the entire period to which hedge accounting is being applied. De-
rivative instruments should not be retroactively designated as
hedges if appropriate contemporaneous documentation of the
election and periodic assessment of effectiveness did not occur in
conformity with FASB Statement No. 133.
Also, as a reminder, guidance to assist with planning and perform-
ing auditing procedures for financial statement assertions about
derivative instruments and hedging activities can be found in SAS
No. 92, Auditing Derivative Instruments, Hedging Activities, and
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Investments in Securities, and the Audit Guide Auditing Derivative
Instruments, Hedging Activities, and Investments in Securities. In
SAS No. 92 (AU sec. 332.21-.58), auditors will find examples of
substantive procedures that address assertions about derivatives.
Also, auditors of health care organizations applying hedge ac-
counting will find in SAS No. 92 (AU sec. 332.52-.53) a discus-
sion of considerations about hedging activities. That discussion
states that auditors should gather evidential matter to:
• Determine whether management complied with the hedge
accounting requirements of GAAP, including designation
and documentation requirements.
• Support management’s expectation at the inception of the
hedge that the hedging relationship will be highly effective
and its periodic assessment of the ongoing effectiveness of
the hedging relationship as required by GAAP.
Reporting Gains and Losses from Extinguishment of Debt
As a reminder, the provisions of FASB Statement No. 145, Rescis-
sion of FASB Statements No. 4, 44, and 64, Amendment of FASB
Statement No. 13, and Technical Corrections, related to the rescis-
sion of FASB Statement No. 4, Reporting Gains and Losses from
Extinguishment of Debt, should be applied in fiscal years begin-
ning after May 15, 2002.
Under FASB Statement No. 4, all gains and losses from extin-
guishment of debt were required to be aggregated and, if mater-
ial, classified as an extraordinary item, net of related income tax
effect. FASB Statement No. 145 eliminated FASB Statement No.
4, and an amendment of that Statement, FASB Statement No.
64, Extinguishments of Debt Made to Satisfy Sinking-Fund Require-
ments, thereby eliminating the requirement that gains and losses
from debt extinguishments be classified as extraordinary items.
Gains and losses from extinguishment of debt should be classified
as extraordinary items only if they meet the criteria in Account-
ing Principles Board (APB) Opinion No. 30, Reporting the Results
of Operations-Reporting the Effects of Disposal of a Segment of a
Business, and Extraordinary, Unusual and Infrequently Occurring
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Events and Transactions. Any gain or loss on extinguishment of
debt that was classified as an extraordinary item in prior periods
presented that does not meet the criteria in APB Opinion No. 30
for classification as an extraordinary item should be reclassified.
Impairment of Long-Lived Assets
Also as a reminder, FASB Statement No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, addresses the finan-
cial accounting and reporting for the impairment or disposal of
long-lived assets. FASB Statement No. 144, among other mat-
ters, superseded FASB Statement No. 121, Accounting for the Im-
pairment of Long-Lived Assets and for Long-Lived Assets to be
Disposed Of. Paragraph 26 of FASB Statement No. 144 provides
guidance on required financial statement disclosures for periods
in which an impairment loss is recognized.
FASB Staff Position, Applicability of FASB Interpretation No. 46,
Consolidation of Variable Interest Entities, to entities subject to
the AICPA Audit and Accounting Guide, Health Care Organizations
FIN No. 46, Consolidation of Variable Interest Entities, was issued
in January 2003 to address consolidation by business enterprises
of certain variable interest entities. Among the scope exceptions
to this Interpretation that are listed in paragraph 4 of the Inter-
pretation are not-for-profit organizations that are subject to the
consolidation requirements of SOP 94-3, Reporting of Related En-
tities by Not-for-Profit Organizations. Not-for-profit organizations
that are subject to the Audit and Accounting Guide Health Care
Organizations are not subject to SOP 94-3.
In July 2003, the FASB issued FSP Applicability of FASB Interpreta-
tion No. 46, Consolidation of Variable Interest Entities, to entities sub-
ject to the AICPA Audit and Accounting Guide, Health Care
Organizations. Among other matters, the FSP states that the scope
exception in paragraph 4(a) of FIN No. 46 applies to all not-for-
profit organizations as defined in FASB Statement No. 117, Financial
Statements of Not-for-Profit Organizations, including health care orga-
nizations subject to the Audit and Accounting Guide Health Care Or-
ganizations. However, a not-for-profit entity used by a business
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enterprise in a manner similar to a variable interest entity in an effort
to circumvent the provisions of FIN No. 46 is subject to the Interpre-
tation. Not-for-profit organizations may be related parties for pur-
poses of applying paragraphs 16 and 17 of FIN No. 46. (See the
related discussion “Proposed FASB Interpretation, Consolidation of
Variable Interest Entities” in the “On the Horizon” section of this Alert.)
Technical Practice Aids
In addition to the recently released TPA listed in the discussion
“AICPA and FASB Pronouncements” in this section of the Alert,
the AICPA Accounting Standards Staff, since the writing of last
year’s Health Care Industry Developments Alert, has also released
several TPAs that specifically relate to health care organizations.9
Technical Practice Aid, Other-than-temporary Impairment Losses
on Investments by Not-for-profit Health Care Organizations
The staff of the AICPA Accounting Standards Team released
“Other-than-temporary Impairment Losses on Investments by
Not-for-profit Health Care Organizations” (AICPA, Technical
Practice Aids, vol. 1, TIS sec. 6400.44). The inquiry in this TPA dis-
cusses paragraph 4.07 of the AICPA Audit and Accounting Guide
Health Care Organizations. Paragraph 4.07 states that a not-for-
profit health care organization should include in the performance
indicator10 other-than-temporary impairment losses on invest-
ments in debt securities and investments in equity securities with
readily determinable fair values. This TPA provides a reply to the
question of what constitutes an other-than-temporary impairment
on such investments for a not-for-profit health care organization. 
9. Section 6400 in the “Technical Questions and Answers” section of Technical Prac-
tice Aids includes Q&As specifically pertaining to health care organizations. The
Q&As are nonauthoritative, and are based on selected practice matters identified
by the staff of the AICPA Technical Hotline and various other bodies within the
AICPA. As of the writing of this Alert, the Q&As discussed in this section of the
Alert are also available on the AICPA Web site, AICPA Online, at www.aicpa.org.
10. Further discussion about the performance indicator is provided in paragraphs
10.17 and 10.18 of the Audit and Accounting Guide Health Care Organizations.
Also, see the discussion “SOP 02-2, Accounting for Derivative Instruments and
Hedging Activities by Not-for-Profit Health Care Organizations, and Clarification of
the Performance Indicator” in this section of the Alert for a related discussion about
amendments to the definition of the performance indicator.
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The reply states the Audit and Accounting Guide Health Care
Organizations uses the term “other than temporary” impairment
losses with the same meaning as in paragraph 16 of FASB State-
ment No. 115, Accounting for Certain Investments in Debt and Eq-
uity Securities. Not-for-profit health care organizations do not
distinguish between securities that are available-for-sale and those
that are held-to-maturity; therefore, the above guidance applies
to all investments in debt and marketable equity securities other
than those that are classified as trading securities. Also, FASB
Statement No. 115 refers to two other sources of literature that
should be considered in evaluating impairment: SAS No. 92, Au-
diting Derivative Instruments, Hedging Activities, and Investments
in Securities, and SEC Staff Accounting Bulletin (SAB) No. 59,
Accounting for Noncurrent Marketable Equity Securities.11
SAS No. 92 (AU sec. 332.47) states that regardless of the valua-
tion method used, GAAP might require recognizing in earnings
an impairment loss for a decline in fair value that is other than
temporary. Determinations of whether losses are other than tem-
porary often involve estimating the outcome of future events. Ac-
cordingly, judgment is required in determining whether factors
exist that indicate that an impairment loss has been incurred at
the end of the reporting period. These judgments are based on
subjective as well as objective factors, including knowledge and
experience about past and current events and assumptions about
future events. SAS No. 92 (AU sec. 332.47) provides examples of
such factors.
The discussion of the guidance in SAB No. 59 notes that the
phrase “other than temporary” should not be interpreted as mean-
ing “permanent.” If an other-than-temporary impairment exists at
the balance sheet date, the security is written down to its fair value
at the balance sheet date, even if the fair value increases between
the balance sheet date and the issuance of the financial statements.
11. Staff Accounting Bulletins (SABs) represent interpretations and practices followed
by the Office of the Chief Accountant and Division of Corporation Finance in ad-
ministering the disclosure requirements of federal securities laws. The statements
in SABs are not rules or interpretations of the Securities and Exchange Commis-
sion (SEC), nor are they published as bearing the SEC’s official approval.
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The reply also notes that additional guidance is contained in
Question 46 in the FASB Special Report A Guide to Implementa-
tion of Statement 115 on Accounting for Certain Investments in
Debt and Equity Securities.
The reply further states that the concept of other-than-temporary
impairment is a matter of professional judgment, depending on
specific facts and circumstances. FASB Statement No. 115 and
other literature do not provide “bright lines” or “safe harbors” to
identify those securities that may have an other-than-temporary
impairment. However, a common feature of all of the guidance is
that a significant decline in fair value below cost or a decline in
fair value below cost for an extended period of time indicates an
other-than-temporary impairment loss.
The issue of other-than-temporary impairment of investments is
also currently being considered by the EITF of the FASB. See the
related discussion “EITF Issue No. 03-1, The Meaning of Other-
Than-Temporary Impairment and Its Application to Certain Invest-
ments,” in the “On the Horizon” section of this Alert. Also, the
Healthcare Financial Management Association (HFMA) has pub-
lished a nonauthoritative document, Issue Analysis No. 02-1,
Recognition of Other-Than-Temporary Decline in Investments for
Tax-Exempt Organizations, to assist not-for-profit health care orga-
nizations with other-than-temporary impairment considerations.
TPAs Pertaining to FASB Statement No. 136, Transfers of
Assets to a Not-for-Profit Organization or Charitable Trust 
That Raises or Holds Contributions for Others
Some not-for-profit organizations have separate fund-raising
foundations (commonly referred to as “institutionally related
foundations”) that solicit contributions on their behalf. In June
1999, the FASB issued FASB Statement No. 136, Transfers of As-
sets to a Not-for-Profit Organization or Charitable Trust That
Raises or Holds Contributions for Others, which (among other
things) provides guidance on the accounting that should be fol-
lowed by such institutionally related foundations and their re-
lated beneficiary organization(s) with respect to contributions
received by the foundation.
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Some institutionally related foundations and their beneficiary or-
ganizations meet the definition of financially interrelated organi-
zations provided in paragraph 13 of FASB Statement No. 136. If
organizations are financially interrelated, FASB Statement No.
136 provides that the balance sheet of the beneficiary organiza-
tion(s) should reflect that organization’s interest in the net assets
of the foundation, and that that interest should be periodically
adjusted to reflect the beneficiary’s share of the changes in the net
assets of the foundation. This accounting is similar to the equity
method of accounting, which is described in APB Opinion No.
18, The Equity Method of Accounting for Investments in Common
Stock. Paragraph 6(b) of APB Opinion No. 18 requires that the
periodic adjustment of the investment be included in the deter-
mination of the investor’s net income.
The staff of the AICPA Accounting Standards Team released a
group of TPAs pertaining to the application of FASB Statement
No. 136. The purpose of the TPAs is to address the net asset clas-
sifications reported by a beneficiary pertaining to its interest in
the net assets of the recipients.
• “Application of FASB Statement No. 136—Classification of a
Beneficiary’s Interest in the Net Assets of a Financially Interre-
lated Fund-Raising Foundation (The beneficiary can influ-
ence the operating and financial decisions of the foundation
to such an extent that the beneficiary can determine the tim-
ing and amount of distributions from the foundation.)”
(AICPA, Technical Practice Aids, vol. 1, TIS sec. 6400.36)
• “Application of FASB Statement No. 136—Classification
of a Beneficiary’s Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (The beneficiary
cannot influence the operating and financial decisions of
the foundation to such an extent that the beneficiary can
determine the timing and amount of distributions from
the foundation.)” (AICPA, Technical Practice Aids, vol. 1,
TIS sec. 6400.37)
• “Application of FASB Statement No. 136—Classification of
a Beneficiary’s Interest in the Net Assets of a Financially In-
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terrelated Fund-Raising Foundation—Does common control
lead to the conclusion that the beneficiary can determine the
timing and amount of distributions from the recipient?”
(AICPA, Technical Practice Aids, vol. 1, TIS sec. 6400.38)
• “Application of FASB Statement No. 136—Classification
of a Beneficiary’s Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (More than one
beneficiary—Some contributions are designated)” (AICPA,
Technical Practice Aids, vol. 1, TIS sec. 6400.39)
• “Application of FASB Statement No. 136—Classification
of a Beneficiary’s Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (The beneficiary
makes an expenditure that meets a purpose restriction on
net assets held for its benefit by the recipient organiza-
tion—The beneficiary can influence the operating and fi-
nancial decisions of the recipient to such an extent that the
beneficiary can determine the timing and amount of distri-
butions from the recipient.)” (AICPA, Technical Practice
Aids, vol. 1, TIS sec. 6400.40)
• “Application of FASB Statement No. 136—Classification
of a Beneficiary’s Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (The beneficiary
makes an expenditure that is consistent with a purpose re-
striction on net assets held for its benefit by the recipient
organization—The beneficiary cannot influence the oper-
ating and financial decisions of the recipient to such an ex-
tent that the beneficiary can determine the timing and
amount of distributions from the recipient.)” (AICPA,
Technical Practice Aids, vol. 1, TIS sec. 6400.41)
• “Application of FASB Statement No. 136—Classification
of a Beneficiary’s Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (Recipient Organi-
zation)—Accounting for Unrealized Gains and Losses on
Investments Held by the Foundation” (AICPA, Technical
Practice Aids, vol. 1, TIS sec. 6400.42)
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• “Application of FASB Statement No. 136—Classification
of Distributions From a Financially Interrelated Fund-
Raising Foundation (Recipient Organization) to a Health
Care Beneficiary” (AICPA, Technical Practice Aids, vol. 1,
TIS sec. 6400.43)
The purpose of TPAs 6400.36 to 6400.42 is to clarify that in cir-
cumstances in which the recipient and the beneficiary are finan-
cially interrelated—
• Beneficiary organizations should segregate the adjustment
into changes in restricted and unrestricted net assets.
(TPAs 6400.36, 6400.37, and 6400.39)
• In circumstances in which the beneficiary can influence
the financial decisions of the recipient organization to
such an extent that the beneficiary can determine the tim-
ing and amount of distributions from the recipient to the
beneficiary, the existence of the recipient organization
should be transparent in determining the net asset classifi-
cations in the beneficiary’s financial statements. In other
words, the recipient cannot impose time or purpose re-
strictions beyond those imposed by the donor. (TPAs
6400.36 and 6400.39)
• In circumstances in which the beneficiary cannot influence the
financial decisions of the recipient organization to such an ex-
tent that the beneficiary can determine the timing and amount
of distributions from the recipient to the beneficiary, the exis-
tence of the recipient organization creates an implied time re-
striction on the beneficiary’s net assets attributable to the
beneficiary’s interest in the net assets of the recipient (in addi-
tion to any other restrictions that may exist). Accordingly, in
recognizing its interest in the net assets of the recipient organi-
zation and the changes in that interest, the beneficiary should
classify the resulting net assets and changes in those net assets
as temporarily restricted (unless donors placed permanent re-
strictions on their contributions). (TPA No. 6400.37)
• In circumstances in which the beneficiary can influence
the financial decisions of the recipient organization to such
50
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an extent that the beneficiary can determine the timing
and amount of distributions from the recipient to the ben-
eficiary and some net assets held by the recipient for the
benefit of the beneficiary are subject to purpose restrictions
(for example, net assets of the recipient restricted to the
beneficiary’s purchase of property, plant and equipment),
expenditures by the beneficiary that meet those purpose re-
strictions result in the beneficiary (and recipient) reporting
reclassifications from temporarily restricted to unrestricted
net assets (assuming that the beneficiary has no other net
assets subject to similar purpose restrictions), unless those
net assets are subject to time restrictions that have not ex-
pired, including time restrictions that are implied on con-
tributed long-lived assets as a result of the beneficiary’s
accounting policy pursuant to paragraph 16 of FASB
Statement No. 116, Accounting for Contributions Received
and Contributions Made. (If those net assets are subject to
time restrictions that have not expired and the beneficiary
has other net assets with similar purpose restrictions, the
restrictions on those other net assets would expire in con-
formity with FASB Statement No. 116. The TPAs do not,
however, establish a hierarchy pertaining to which restric-
tions are released first—restrictions on net assets held by
the recipient or purpose restrictions on net assets held by
the beneficiary.) (TPA 6400.40)
• In circumstances in which the beneficiary cannot influence
the financial decisions of the recipient organization to such
an extent that the beneficiary can determine the timing and
amount of distributions from the recipient to the beneficiary
and some net assets held by the recipient for the benefit of
the beneficiary are subject to purpose restrictions, though
not subject to time restrictions other than the implied time
restrictions that exist because the beneficiary cannot deter-
mine the timing and amount of distributions from the recip-
ient to the beneficiary, expenditures by the beneficiary that
are consistent with those purpose restrictions should not re-
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sult in the beneficiary reporting a reclassification from tem-
porarily restricted to unrestricted net assets, subject to the
exceptions in the following sentence. Expenditures by the
beneficiary that are consistent with those purpose restric-
tions should result in the beneficiary reporting a reclassifica-
tion from temporarily restricted to unrestricted net assets if
(a) the recipient has no discretion in deciding whether the
purpose restriction is met12 or (b) the recipient distributes or
obligates itself to distribute to the beneficiary amounts at-
tributable to net assets restricted for the particular purpose,
or otherwise indicates that the recipient intends for those net
assets to be used to support the particular purpose as an ac-
tivity of the current period. In all other circumstances, (a)
purpose restrictions and (b) implied time restrictions on the
net assets attributable to the interest in the recipient organi-
zation exist and have not yet expired. (However, if the bene-
ficiary has other net assets with similar purpose restrictions,
those restrictions would expire in conformity with FASB
Statement No. 116. The TPAs do not establish a hierarchy
pertaining to which restrictions are released first—restric-
tions on net assets held by the recipient or restrictions on net
assets held by the beneficiary.) (TPA 6400.41)
• In circumstances in which the beneficiary can influence
the financial decisions of the recipient to such an extent
that the beneficiary can determine the timing and amount
of distributions from the recipient to the beneficiary,
changes in the beneficiary’s interest in the net assets of a re-
cipient organization attributable to unrealized gains and
52
12. In some circumstances, the purpose restrictions may be so broad that the recipient
organization has discretion in deciding whether expenditures by the beneficiary
that are consistent with those purpose restrictions actually meet those purpose re-
strictions. For example, the recipient’s net assets may have arisen from a contribu-
tion that was restricted for the beneficiary’s purchase of research equipment with
no particular research equipment specified. Purchasing an XYZ microscope, which
is consistent with that purpose restriction, may or may not meet that purpose re-
striction, depending on the decision of the recipient. In contrast, the net assets may
have arisen from a contribution that was restricted for an XYZ microscope. Pur-
chasing an XYZ microscope, which also is consistent with that purpose restriction,
would result in the recipient having no discretion in determining whether that pur-
pose restriction is met.
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losses on investments should be included or excluded from
the performance indicator in conformity with Chapters 4
and 10 of the Audit and Accounting Guide Health Care
Organizations, in the same manner that they would have
been had the beneficiary had the transactions itself. Simi-
larly, in applying the guidance in Chapters 4 and 10, the
determination of whether amounts are included or ex-
cluded from the performance measure should comprehend
that if the beneficiary cannot influence the financial deci-
sions of the recipient organization to such an extent that
the beneficiary can determine the timing and amount of dis-
tributions from the recipient to the beneficiary, an implied
time restriction exists on the beneficiary’s net assets attribut-
able to the beneficiary’s interest in the net assets of the recip-
ient (in addition to any other restrictions that may exist).
Accordingly, in circumstances in which the beneficiary can-
not influence the financial decisions of the recipient organi-
zation to such an extent that the beneficiary can determine
the timing and amount of distributions from the recipient to
the beneficiary, the beneficiary should classify the resulting
net assets and changes in those net assets as temporarily re-
stricted (unless donors placed permanent restrictions on
their contributions) and therefore exclude those changes
from the performance indicator. (TPA 6400.42)
• In circumstances in which the recipient organization and
the beneficiary are both controlled by the same organiza-
tion, entities should consider the specific facts and circum-
stances to determine whether the beneficiary can influence
the financial decisions of the recipient organization to such
an extent that the beneficiary can determine the timing
and amount of distributions from the recipient to the ben-
eficiary. (TPA 6400.38)
GASB Pronouncements and Other Accounting Guidance for
Governmental Health Care Entities
Three statements and a technical bulletin were issued by the
GASB since the writing of last year’s Alert. Brief summaries of
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those pronouncements having particular significance for govern-
mental health care entities follow. For more information on
GASB accounting standards, including any standards that may
be issued subsequent to the writing of this Alert, please refer to
the GASB Web site at www.gasb.org.
GASB Statement No. 40, Deposit and Investment Risk Disclosures
In March 2003, the GASB issued GASB Statement No. 40, Deposit
and Investment Risk Disclosures, an amendment of GASB Statement
No. 3, Deposits with Financial Institutions, Investments (including
Repurchase Agreements), and Reverse Repurchase Agreements. 
GASB Statement No. 40 establishes and modifies disclosure re-
quirements related to investment risks: credit risk (including cus-
todial credit risk and concentrations of credit risk), interest rate
risk, and foreign currency risk. GASB Statement No. 40 also es-
tablishes and modifies disclosure requirements for deposit risks:
custodial credit risk and foreign currency risk.
The provisions of GASB Statement No. 40 are effective for finan-
cial statements for periods beginning after June 15, 2004. Earlier
application is encouraged.
GASB Statement No. 42, Accounting and Financial Reporting
for Impairment of Capital Assets and for Insurance Recoveries
In November 2003, the GASB issued GASB Statement No. 42,
Accounting and Financial Reporting for Impairment of Capital As-
sets and for Insurance Recoveries. Among other matters, the State-
ment requires that governments evaluate major events affecting
capital assets to determine whether they are impaired, and to re-
port the effects of capital asset impairment in their financial state-
ments when it occurs. GASB Statement No. 42 is effective for
fiscal years beginning after December 15, 2004.
GASB Technical Bulletin 2003-1, Disclosure Requirements for
Derivatives Not Reported at Fair Value on the Statement of Net Assets
In June 2003, the GASB issued Technical Bulletin (TB) 2003-1,
Disclosure Requirements for Derivatives Not Reported at Fair Value on
the Statement of Net Assets, to supersede GASB TB 94-1, Disclosures
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about Derivatives and Similar Debt and Investment Transactions.
Among other matters, TB 2003-1 provides an updated definition of
derivatives and requires expanded disclosures related to derivative
transactions. TB 2003-1 is effective for financial statements for peri-
ods ending after June 15, 2003, with early application encouraged.
Accounting Issues and Developments
Claims-Made Insurance Coverage
EITF Issue No. 03-3, Applicability of Topic D-79 to Claims-Made
Insurance Policies, provides guidance on determining whether a
claims-made insurance policy includes a retroactive provision. If a
claims-made insurance policy contains a retroactive provision,
the retroactive and prospective provisions of the policy should be
accounted for separately, if practicable. EITF Issue No. 03-3 in-
cludes a list of indicators that a claims-made insurance policy
does not contain a retroactive provision and, therefore, should be
accounted for on a prospective basis.
Exhibit 03-3A to EITF Issue No. 03-3 provides examples to illus-
trate the application of the EITF consensus on EITF Issue 03-3.
This exhibit includes an example illustrating an evaluation of all
relevant facts and circumstances by a health care provider to deter-
mine whether the provider’s medical malpractice claims-made in-
surance policy does or does not contain any retroactive provisions.
The EITF directed FASB staff to codify the guidance for claims-
made insurance policies by an insured entity and retroactive insur-
ance contracts in Issue No. 03-3, Issue No. 86-12, Accounting by
Insureds for Claims-Made Insurance Policies, and Topic No. D-79 (and
the examples discussed in each of those Issues) into one EITF Issue
No. 03-8, Accounting for Claims-Made Insurance and Retroactive In-
surance Contracts by the Insured Entity. At the November 12–13 EITF
meeting, the EITF affirmed the final version of the codification.
Split Interest Agreements
Not-for-profit health care organizations may have entered into
split interest agreements that promised beneficiaries payout rates
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that are higher than the rates the not-for-profit health care orga-
nizations are currently earning on their investments. The current
market conditions have implications for both accounting and
donor relations.
Not-for-profit health care organizations that did not lock-in re-
turns on investments adequate to fund those obligations to third-
party beneficiaries (that is, equal to or exceeding the discount rate
used to compute the fair value of the liability) may face the fol-
lowing issues:
• For charitable gift annuities held as general assets and
obligations of the not-for-profit health care organization,
the not-for-profit health care organization is in effect in-
curring economic losses each period in which the interest
rate earned is below the initial discount rate. Those losses
are not reflected in the financial statements, however, be-
cause the interest rate used to discount the liability to the
donor is not adjusted to reflect current market conditions.
Not-for-profit health care organizations should consider
disclosing such circumstances.
• For annuity trust agreements, continuing to pay a rate
greater than is earned raises the possibility that trust assets
may be depleted to the extent that at a future date there
will be insufficient assets to fund obligations to income
beneficiaries. In such circumstances, the trust may even-
tually have to cease making the payments. Publicity about
such conditions and risks, which may not have been clar-
ified in the solicitation or afterwards, could adversely af-
fect the not-for-profit health care organization’s ability to
enter into similar planned-giving arrangements in the fu-
ture. Not-for-profit health care organizations should con-
sider disclosing such circumstances. The concern about
depleting assets to the extent that payments cease would
not apply to typical pooled-life income funds because
beneficiaries receive only the income earned on the trust.
It also would not apply to unitrusts because the payment
amount changes annually as the fair value of the unitrust
assets changes.
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Even though unitrusts and pooled-life income funds may not be
depleted to the extent that payments cease, the current market
conditions may have significantly reduced the income of pooled
income funds or the fair value of assets in charitable unitrusts. As
a result, the payments to beneficiaries also may have been signifi-
cantly reduced. Not-for-profit health care organizations that do
not inform beneficiaries about the impact of market conditions
on the amount of their distributions before the decreases in pay-
ments occur may face problems of donor alienation. The effects of
potential donor alienation on future gifts should be considered.
Derivative Accounting and Split Interest Agreements 
Under FASB Derivatives Implementation Group Issue B35, Em-
bedded Derivatives: Application of Statement 133 to a Not-for-
Profit Organization’s Obligation Arising from an Irrevocable
Split-Interest Agreement, many split interest agreements will re-
quire bifurcation and derivative accounting. For lead interest
agreements in particular, in circumstances in which the not-for-
profit health care organization has a liability to a beneficiary, even
if the lead interest is a fixed payment, as long as the liability is
variable and the agreement is period certain, it will qualify as a
derivative. This is because the liability to the third party will usu-
ally vary based on the fair value of investments.
Accounting and Disclosure Requirements for Guarantees
Auditors of health care organizations will need to consider the
accounting and disclosure requirements of FIN No. 45, Guaran-
tor’s Accounting and Disclosure Requirements for Guarantees, In-
cluding Indirect Guarantees of Indebtedness of Others, when their
health care organization clients are issuers of guarantees. This In-
terpretation of FASB Statement No. 5, Accounting for Contingen-
cies, FASB Statement No. 57, Related Party Disclosures, and
FASB Statement No. 107, Disclosures about Fair Value of Finan-
cial Instruments, clarifies:
• Guarantors are required to recognize a liability at the in-
ception of a guarantee for their obligations undertaken in
issuing certain guarantees (the Interpretation does not
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prescribe a specific account for the offsetting entry or a
specific approach for subsequently measuring the recog-
nized liability).
• The disclosures required by guarantors about their obliga-
tions under certain guarantees in the interim and annual
financial statements.
FIN No. 45 also rescinds and incorporates without change the
guidance in FIN No. 34, Disclosure of Indirect Guarantees of In-
debtedness of Others.
FIN No. 45 does not apply to all guarantees. The provisions of
FIN No. 45 apply if the guarantee contract has any of the charac-
teristics that are provided in paragraph 3 of the Interpretation.
Based on these characteristics, loan commitments, for example,
are excluded from the scope, as are indemnifications or guaran-
tees of an entity’s own future performance. Performance guaran-
tees (such as performance standby letters of credit) and indirect
guarantees of indebtedness of others (such as agreements to ad-
vance funds if a second entity’s net income, coverage of fixed
charges, or working capital falls below a specified minimum) are
examples of guarantees that are included in the scope.
Notwithstanding these characteristic-based scope provisions in
paragraph 3 of the Interpretation, FIN No. 45 also includes a
number of scope exceptions that should be considered to deter-
mine if the requirements of FIN No. 45 apply. Some scope ex-
ceptions (see paragraph 6 of the Interpretation) exempt the
guarantee contract from the entire Interpretation. Others (see
paragraph 7 of the Interpretation) exempt the guarantee from the
Interpretation’s initial recognition and initial measurement provi-
sions only. Examples of guarantees that are subject only to the
disclosure requirements of FIN No. 45 as a result of the scope ex-
ceptions in paragraph 7 of the Interpretation include: a guarantee
that is accounted for as a derivative instrument at fair value under
FASB Statement No. 133, a guarantee issued either between par-
ents and their subsidiaries or between corporations under com-
mon control, a parent’s guarantee of its subsidiary’s debt to a
third party (whether the parent is a corporation or an individual),
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and a subsidiary’s guarantee of the debt owed to a third party by
either its parent or another subsidiary of that parent.
The disclosures required by FIN No. 45 do not eliminate or af-
fect the requirement in FASB Statement No. 107, as amended,
that certain entities disclose the fair value of their financial guar-
antees issued. Also, in those cases where guarantees are issued to
benefit entities that meet the definition of a related party in para-
graph 24(f ) of FASB Statement No. 57, such as joint ventures,
equity method investees, and certain entities for which control-
ling financial interest cannot be assessed by analyzing voting in-
terests, FIN No. 45 disclosures are incremental to the disclosures
required by FASB Statement No. 57.
Compliance With Debt Covenants
Health care organizations that are experiencing losses, or deterio-
ration in operating results or cash flows, may not be in compli-
ance with debt covenants, which could result in financial
penalties, remediation efforts, or the debt being callable. Auditors
should also consider the need to perform additional auditing pro-
cedures to assess the impact of other changes, such as accounting
changes and reporting changes, on debt covenants. If the health
care organization is not in compliance with debt covenants, the
auditor should consider whether management has appropriately
disclosed any contingencies and other items that may require dis-
closure. The guidance in Auditing Interpretation No. 3, “The
Impact on an Auditor’s Report of an FASB Statement Prior to the
Statement’s Effective Date,” of SAS No. 1, Codification of Audit-
ing Standards and Procedures (AICPA, Professional Standards, vol.
1, AU sec. 9410.13–.18), among other matters, provides that au-
ditors should consider whether disclosure is needed for the effects
that may result upon the required future adoption of an account-
ing principle, such as, for example, the future adoption of an ac-
counting principle that may result in a reduction to stockholder’s
equity and cause the entity to be in violation of its debt
covenants, which in turn may accelerate the due date for repay-
ment of debt.
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On the Horizon
Auditors should keep abreast of auditing and accounting devel-
opments and upcoming guidance that may affect their engage-
ments. Auditors of publicly traded health care companies should
keep abreast of standards and rules issued by the PCAOB. The
AICPA general Audit Risk Alert—2003/04 (product no.
022334kk) summarizes some of the more significant ongoing
projects and exposure drafts outstanding. Presented below is brief
information about certain ongoing projects and exposure drafts
that are especially relevant to the health care industry. Remember
that exposure drafts are nonauthoritative and cannot be used as a
basis for changing GAAP or GAAS.
The following table lists the various standard-setting bodies’ Web
sites where information may be obtained on outstanding expo-
sure drafts, including downloading a copy of the exposure draft.
These Web sites contain much more in-depth information about
proposed standards and other projects in the pipeline. Many
more accounting and auditing projects exist beyond those dis-
cussed below and in the general Audit Risk Alert—2003/04.
Readers should refer to information provided by the various stan-
dard-setting bodies for further information.
Standard-Setting Body Web Site 
AICPA Auditing www.aicpa.org/members/div/auditstd/drafts.htm
Standards Board 
(Note that for audits of public 
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Help Desk—The AICPA’s standard-setting committees pub-
lish exposure drafts of proposed professional standards exclu-
sively on AICPA Online. The AICPA will notify interested
parties by e-mail about new exposure drafts. To have your e-
mail address put on the notification list for all AICPA exposure
drafts, send your e-mail address to memsat@aicpa.org. Indi-
cate “exposure draft e-mail list” in the subject header field to
help process the submission more efficiently. Include your full
name, mailing address, and, if available, your membership and
subscriber number in the message.
Accounting Pipeline
Combinations of Not-for-Profit Organizations
In November 1999, the FASB affirmed its earlier decision to un-
dertake a project on combinations of not-for-profit organizations
separate from its business combinations project. The scope of the
project on combinations of not-for-profit organizations includes:
• Combinations between two or more not-for-profit organizations.
• Acquisition of a for-profit business enterprise by a not-for-
profit organization.
As a result of that decision, FASB Statement No. 141, Business
Combinations, does not apply to certain combinations, including
a combination involving two or more not-for-profit organiza-
tions, or the acquisition of a for-profit business entity by a not-
for-profit organization. For those combinations, the guidance in
APB Opinion No. 16, Business Combinations, still applies. Thus,
GAAP does not change for those types of combinations. Not-
for-profit health care organizations should continue to follow the
guidance in the Audit and Accounting Guide Health Care Orga-
nizations and in APB Opinion No. 16, as amended by pro-
nouncements prior to the issuance of FASB Statement No. 141.
Pronouncements that were amended by FASB Statement No.
141 should be applied by those entities as though that Statement
had not amended them. In addition, in applying the guidance
included in APB Opinion No. 16, not-for-profit health care
organizations should continue to apply the amendments to
that Opinion that were included in FASB Statement No. 121,
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Accounting for the Impairment of Long-Lived Assets and for Long-
Lived Assets to Be Disposed Of, even though FASB Statement No.
121 was superseded by FASB Statement No. 144, Accounting for
the Impairment or Disposal of Long-Lived Assets.
Also, FASB Statement No. 142, Goodwill and Other Intangible
Assets, is not applicable to goodwill and other intangible assets
arising from combinations between not-for-profit organizations
or arising from the acquisition of a for-profit business entity by a
not-for-profit organization until the FASB completes its delibera-
tion with respect to the application of the purchase method by
those entities.
You can obtain additional information about the status of this
project, including a summary of tentative decisions reached by
the FASB on this project, on the FASB Web site at www.fasb.org.
As of the writing of this Alert, the FASB plans to issue an expo-
sure draft of its proposed standard on not-for-profit combina-
tions in 2004.
Proposed FASB Interpretation, Consolidation of Variable
Interest Entities
In October 2003, the FASB released an exposure draft of a pro-
posed FIN, Consolidation of Variable Interest Entities, a modifica-
tion of FIN No. 46. Among other matters, the proposed FIN
would clarify that the scope exception provided in paragraph 4(a)
of FIN No. 46 applies to all entities that meet the definition of
not-for-profit organizations in FASB Statement No. 117, Finan-
cial Statements of Not-for-Profit Organizations, which includes
not-for-profit health care organizations. The proposed FIN
would be effective for financial statements issued for the first re-
porting period ending after December 15, 2003, for variable in-
terests and variable interest entities to which the provisions of
FIN No. 46 have been applied. For variable interest entities to
which the provisions of FIN No. 46 have not been applied, the
proposed FIN would be applied in accordance with the effective
date and transition provisions in FIN No. 46 and related FSPs.
(See the related discussion “FASB Staff Position, Applicability of
FASB Interpretation No. 46, Consolidation of Variable Interest
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Entities, to entities subject to the AICPA Audit and Accounting
Guide Health Care Organizations” in the “New Accounting Pro-
nouncements and Other Guidance” section of this Alert.)
EITF Issue No. 03-1, The Meaning of Other-Than-Temporary
Impairment and Its Application to Certain Investments
The current issues of the EITF of the FASB include proposed
guidance for assessing other-than-temporary impairment. The
issue is to determine the meaning of other-than-temporary im-
pairment and its application to investments accounted for under
the cost method or equity method, and investments classified as
either available-for-sale or held-to-maturity under FASB State-
ment No. 115, Accounting for Certain Investments in Debt and Eq-
uity Securities (including individual securities and mutual funds).
At the July 31, 2003, EITF meeting, the EITF discussed separate
impairment models proposed by the FASB staff for each of the
following categories of investments: (1) FASB Statement No. 115
and FASB Statement No. 124, Accounting for Certain Investments
Held by Not-for-Profit Organizations, equity securities, (2) FASB
Statement No. 115 and FASB Statement No. 124 debt securities,
(3) cost method investments, and (4) equity method investments.
The EITF also requested that the FASB staff consider further the
implications of including within or excluding from the scope of
EITF Issue No. 03-1 investments of not-for-profit organizations.
At the November 12–13, 2003, EITF meeting, the EITF reached
a consensus on one issue. The FASB ratified the consensus on that
one issue at its November 25, 2003, meeting. As of the writing of
this Alert, further discussion of EITF Issue No. 03-1 is planned at
a future EITF meeting. Readers should be alert to the ratification
of any other final consensus reached on this EITF Issue. See the
FASB Web site at www.fasb.org for updated information.
Auditing Pipeline
Substantial Changes to Audit Process Proposed for Non-Public
Companies (Note: These changes do not apply to the audits of
public companies.)
In December 2002, the AICPA’s ASB issued an exposure draft
proposing seven new SASs relating to the auditor’s risk assess-
ARA Health Care.qxd  12/23/2003  3:54 PM  Page 63
ment process. The ASB believes that the requirements and guid-
ance provided in the proposed SASs, if adopted, would result in a
substantial change in audit practice and in more effective audits.
The primary objective of the proposed SASs is to enhance audi-
tors’ application of the audit risk model in practice by requiring:
• More in-depth understanding of the entity and its envi-
ronment, including its internal control, to identify the
risks of material misstatement in the financial statements
and what the entity is doing to mitigate them.
• More rigorous assessment of the risks of material misstate-
ment of the financial statements based on that understanding.
• Improved linkage between the assessed risks and the na-
ture, timing, and extent of audit procedures performed in
response to those risks.
The exposure draft consists of the following proposed SASs:
• Amendment to Statement on Auditing Standards No. 95,
Generally Accepted Auditing Standards
• Audit Evidence
• Audit Risk and Materiality in Conducting an Audit
• Planning and Supervision
• Understanding the Entity and Its Environment and Assessing
the Risks of Material Misstatement
• Performing Audit Procedures in Response to Assessed Risks and
Evaluating the Audit Evidence Obtained
• Amendment to Statement on Auditing Standards No. 39,
Audit Sampling
The proposed SASs establish standards and provide guidance
concerning the auditor’s assessment of the risks of material mis-
statement in a financial statement audit, and the design and per-
formance of audit procedures whose nature, timing, and extent
are responsive to the assessed risks. Additionally, the proposed
SASs establish standards and provide guidance on planning and
64
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supervision, the nature of audit evidence, and evaluating whether
the audit evidence obtained affords a reasonable basis for an opin-
ion regarding the financial statements under audit.
The proposed SASs would be effective for audits of financial
statements for periods beginning on or after December 15, 2004,
in order to allow time for auditors to revise their methodologies
and train their personnel to plan the initial application of these
standards to their audits. Readers can access the proposed stan-
dards at AICPA Online at www.aicpa.org.
Exposure Draft of Proposed GASB Statement
The following exposure draft of a proposed GASB Statement,
which is particularly relevant to governmental health care organi-
zations, was outstanding as of the writing of this Alert. Accounting
and Financial Reporting by Employers for Postemployment Benefits
Other Than Pensions proposes standards for how governmental
employers should report postemployment health care benefits, as
well as other forms of postemployment benefits (for example, life
insurance) when provided separately from a pension plan. The
GASB proposed that the Statement become effective in three an-
nual phases (using the same dollar cutoffs as was done with
GASB Statement No. 34), starting for periods beginning after
June 15, 2006. Issuance of a final Statement is expected in 2004.
See the GASB Web site at www.gasb.org for updated information
about this exposure draft and other GASB technical projects.
The Role of the AICPA Health Care Expert Panel
In the fall of 2003, the AICPA created an expert panel to focus on
accounting and attest matters for CPAs in the health care indus-
try. The Health Care Expert Panel is one of a number of industry-
specific panels that have been created as part of the AICPA’s effort
to revamp the AICPA’s volunteer structure. The Health Care Ex-
pert Panel will identify and discuss industry-specific emerging is-
sues; identify areas where additional guidance is needed; work
with the appropriate standard-setting bodies to reach a resolution
benefiting the public interest; assist the AICPA with maintaining
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the Audit and Accounting Guide Health Care Organizations and
Audit Risk Alert Health Care Industry Developments; conduct liai-
son activities with health care industry associations and regula-
tors, including the HFMA and HHS; and advise and assist in the
development of AICPA products and services related to the in-
dustry (for example, conferences and CPE courses).
Resource Central
Education courses, Web sites, publications, and other resources
available to CPAs
AICPA Products and Publications
In addition to the AICPA publications already discussed in this
Alert, the following AICPA products and publications may also
be of interest to auditors of health care organizations.
Checklist and Illustrative Financial Statements for 
Health Care Organizations
Checklist and Illustrative Financial Statements for Health Care Orga-
nizations (product no. 009023kk) is a nonauthoritative financial
accounting and reporting practice aid that is updated annually.
Audit and Accounting Manual
The Audit and Accounting Manual (product no. 005133kk) is a
valuable nonauthoritative practice tool designed to provide assis-
tance for audit, review, and compilation engagements. It contains
numerous practice aids, samples, and illustrations, including
audit programs; auditors’ reports; checklists; and engagement let-
ters, management representation letters, and confirmation letters.
Auditing Governmental Financial Statements: Programs and
Other Practice Aids
The AICPA has developed this new nonauthoritative Practice Aid
(product no. 006602kk), expected to be available in January 2004,
for auditors as a companion to the Audit and Accounting Guide
Audits of State and Local Governments (GASB 34 Edition). Although
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this Practice Aid does not address concerns unique to the audits of
the basic financial statements presented by special-purpose govern-
ments, you can use it as a “core” tool for those engagements. 
Understanding and Implementing GASB’s New Financial
Reporting Model: A Question and Answer Guide for Preparers
and Auditors of State and Local Governmental Financial
Statements (Revised Edition)
This nonauthoritative publication (product no. 022516kk) provides
a summary of the significant portions of GASB Statement No. 34
and related GASB publications in a question-and-answer format.
AICPA reSOURCE
AICPA reSOURCE Online offers two online research libraries.
The AICPA reference library provides instant access to the
AICPA’s Professional Standards, Technical Practice Aids, current
Audit and Accounting Guides, current Audit Risk Alerts, and
Accounting Trends and Techniques. The AICPA+FASB reference li-
brary, in addition to these AICPA materials, includes FASB and
AICPA original pronouncements, current text, EITF abstracts,
implementation guides, and a comprehensive topical index. To
subscribe, go online at www.cpa2biz.com.
The AICPA also has a CD-ROM product titled reSOURCE:
AICPA’s Accounting and Auditing Literature. This CD-ROM also
enables subscription access to the AICPA Professional Literature
products in a Windows format.
For more information about these AICPA publications and prod-
ucts, call the AICPA (Member Satisfaction) at (888) 777-7077.
Education Courses
The AICPA has developed a number of CPE courses that are
valuable to CPAs working in the health care industry, many of
them available for both group study and self-study. Some of the
AICPA’s CPE products are discussed in this section of the Alert.
For more information about AICPA CPE products, call the
AICPA (Member Satisfaction) at (888) 777-7077.
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Online CPE
AICPA InfoBytes. AICPA InfoBytes, offered exclusively through
cpa2biz.com, is the AICPA’s flagship online learning product. Se-
lected as one of Accounting Today’s top 100 products for 2003,
AICPA InfoBytes now offers a free trial subscription to the entire
product for up to 30 days. AICPA members pay $149 ($369
nonmembers) for a new subscription and $119 ($319 nonmem-
bers) for the annual renewal. Divided into one- and two-credit
courses that are available 24/7, AICPA InfoBytes offers hundreds
of hours of learning in a wide variety of topics. To register or learn
more visit www.cpa2biz.com.
National Healthcare Industry Conference
The annual AICPA National Healthcare Industry Conference, devel-
oped in cooperation with the HFMA, provides up-to-date informa-
tion on the latest developments in health care issues. To get
information, call (888)-777-7077 or go online at www.cpa2biz.com.
Member Satisfaction Center
To order AICPA products, receive information about AICPA ac-
tivities, and find help on your membership questions, call the
AICPA Member Satisfaction Center at (888) 777-7077.
Hotlines
Accounting and Auditing Technical Hotline
The AICPA Technical Hotline answers members’ inquiries about
accounting, auditing, attestation, compilation, and review ser-
vices. Call (888) 777-7077.
Ethics Hotline
Members of the AICPA Professional Ethics Team answer in-
quiries concerning independence and other behavioral issues re-
lated to the application of the AICPA Code of Professional
Conduct. Call (888) 777-7077.
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Web Sites
AICPA Online and CPA2Biz
AICPA Online, www.aicpa.org, offers CPAs the unique opportu-
nity to stay abreast of matters relevant to the CPA profession.
AICPA Online informs you of developments in the accounting
and auditing world as well as developments in congressional and
political affairs affecting CPAs. 
In addition, CPA2Biz.com offers all the latest AICPA products,
including the Audit Risk Alerts, Audit and Accounting Guides,
the professional standards, and CPE courses.
Other Helpful Web Sites
Further information on matters addressed in this Audit Risk Alert
is available through various publications and services offered by a
number of organizations. Some of those organizations are listed in
the “Information Sources” table at the end of this Alert.
This Audit Risk Alert replaces the Health Care Industry Develop-
ments—2002/03 Audit Risk Alert. The Health Care Industry De-
velopments Audit Risk Alert is published annually. As you
encounter audit or industry issues that you believe warrant discus-
sion in next year’s Alert, please feel free to share them with us. Any
other comments that you have about the Alert would also be ap-






Jersey City, NJ 07311-3881
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INFORMATION SOURCES
Organization Web Site
American Institute of Certified Public Accountants www.aicpa.org
Harborside Financial Center
201 Plaza Three
Jersey City, NJ 07311-3881
Telephone: (888) 777-7077 
(Member Satisfaction Center)
Centers for Medicare and Medicaid Services www.cms.gov






General Accounting Office www.gao.gov






Internal Revenue Service www.irs.gov
Municipal Securities Rulemaking Board www.msrb.org
National Federation of Municipal Analysts www.nfma.org
U.S. Department of Health and Human Services www.hhs.gov
U.S. Office of Management and Budget www.omb.gov 
70
ARA Health Care.qxd  12/23/2003  3:54 PM  Page 70
71
APPENDIX
Health Care Industry-Specific Conditions That
May Indicate the Presence of Fraud
The health care industry-specific fraud risk factors that follow in-
clude interpretations of some of the example risk factors found in
Statement on Auditing Standards (SAS) No. 99, Consideration of
Fraud in a Financial Statement Audit (AICPA, Professional Stan-
dards, vol. 1, AU sec. 316), tailored to the health care industry.
They should be used to supplement, but not replace, the example
risk factors included in SAS No. 99.1
One of the key changes to audit practice that SAS No. 99 sought
to impose was a better linking of auditor response to identified
fraud risk factors. To help you develop more effective audit pro-
grams, the following sections also contain example audit proce-
dures you may perform in response to specifically identified risks.
Two types of fraud are relevant to the auditor’s consideration:
• Fraudulent financial reporting
• Misappropriation of assets 
For each of these types of fraud, the risk factors are further classi-
fied based on the three conditions generally present when mater-




1. This listing of industry-specific conditions for the health care industry can also be
found in “Appendix A: Industry-Specific Conditions That May Indicate the Presence
of Fraud” to the Practice Aid Fraud Detection in a GAAS Audit: SAS No. 99 Imple-
mentation Guide. Among the other industries presented in that appendix are state and
local governmental entities and not-for-profit organizations receiving federal awards.
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Although the risk factors cover a broad range of situations, they
are only examples and, accordingly, the auditor may wish to con-
sider additional or different risk factors. Also, the order of the ex-
amples of risk factors provided is not intended to reflect their
relative importance or frequency of occurrence.
Part 1: Fraudulent Financial Reporting
An auditor’s interest specifically relates to fraudulent acts that
cause a material misstatement of financial statements. Some of
the following factors and conditions are present in entities where
specific circumstances do not present a risk of material misstate-
ment. Also, specific controls may exist that mitigate the risk of
material misstatement due to fraud, even though risk factors or
conditions are present. When identifying risk factors and other
conditions, you should assess whether those risk factors and con-
ditions, individually and in combination, present a risk of mater-
ial misstatement of the financial statements.
Incentives/Pressures
1. Financial stability or profitability is threatened by eco-
nomic, industry, or entity operating conditions, such as (or
as indicated by):
a. High vulnerability to rapid changes, such as changes in
technology, product obsolescence, or interest rates.
(1) A failure or inability to keep pace with the rapid
growth on medical technology, if the financial sta-
bility or profitability of the particular entity is
placed at risk due to that failure or inability.
b. Intense scrutiny by governmental bodies, watchdog
groups, and other interested parties of the organization,
placing unusual pressure on management. Situations
targeted for investigation might include:
(1) Improper billing of services performed by residents.
(2) Inappropriate transfers or discharges.
(3) Illegal arrangements involving physicians.
(4) Improper referrals.
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(5) Billing for nonapproved medical devices.
(You should be aware of the existence of these types of situa-
tions in the health care industry. If these situations are iden-
tified on an engagement, they should be considered in the
auditor’s assessment of material misstatement due to fraud.)
2. Excessive pressure exists for management to meet the require-
ments or expectations of third parties due to the following:
a. Intense pressure from governmental bodies and health
maintenance organizations to embrace cost contain-
ment and efficiency enhancement programs.
3. Management or the board of directors’ personal net worth
is threatened by the entity’s financial performance arising
from the following:
a. Bonuses or incentive compensation are tied to operat-
ing results.
Opportunities
1. The nature of the industry or the entity’s operations pro-
vides opportunities to engage in fraudulent financial re-
porting that can arise from the following:
a. The existence of many complex third-party payor con-
tracts.
2. There is ineffective monitoring of management as a result
of the following:
a. A board of directors mainly composed of local business
people and doctors. A board composed of such people,
combined with large available financial resources, cre-
ates the potential for insider business deals.
b. A board of directors composed of people who lack the
necessary experience and skills to properly oversee a
health care organization.
3. Internal control components are deficient as a result of the
following:
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a. Inadequate monitoring of significant controls, includ-
ing automated controls.
(1) Lack of oversight or control of various affiliations
in an integrated health delivery system.
(2) Lack of management review of dispersed locations.
(3) Insufficient board or senior management oversight
of critical processes, such as:
– Establishment of allowance for uncollectible ac-
counts and contractual adjustments, buildup of
unallocated reserve.
– Incident monitoring, followup, and settlement.
– Business affiliations and combinations.
– Regulatory compliance.
Attitudes/Rationalizations
Risk factors reflective of attitudes/rationalizations by board mem-
bers, management, or employees that allow them to engage in
and/or justify fraudulent financial reporting, may not be suscep-
tible to observation by the auditor. Nevertheless, the auditor who
becomes aware of the existence of such information should con-
sider it in identifying the risks of material misstatement arising
from fraudulent financial reporting. For example, auditors may
become aware of the following information that may indicate a
risk factor:
1. Ineffective communication and support of the entity’s val-
ues or ethical standards by management or the communi-
cation of inappropriate values or ethical standards.
a. Lack of an effective corporate compliance program.
2. Management displaying a significant disregard for regula-
tory authorities.
a. Failure to respond to recent regulatory reviews.
3. Attitude that generally accepted accounting principles
(GAAP) is not as strict for nonpublic entities (for example,
often seen in setting up “cookie-jar” reserves or ignoring
other-than-temporary impairments).
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4. Attitude that materiality can be stretched further for not-
for-profits.
Auditor Response
In addition to the sample responses presented in SAS No. 99, an
auditor may want to consider the following response.
Allowance for uncollectible accounts and contractual adjustments. If
there is the risk of material misstatement concerning the al-
lowance for uncollectible accounts and contractual adjustments,
the auditor should consider taking a more substantive approach
to testing the factors used to determine such allowances. Such
steps might include more detailed analytical procedures, such as
analyses of historical contractual adjustments and accounts re-
ceivable runoff (actual cash) by specific payors to the recorded al-
lowance, or the testing and analysis of the collectibility of a
sufficient number of accounts to arrive at an independent conclu-
sion about the adequacy of the allowance.
Part 2: Misappropriation of Assets
An auditor’s interest specifically relates to fraudulent acts that
cause a material misstatement of financial statements. Some of
the following factors and conditions are present in entities where
specific circumstances do not present a risk of material misstatement.
Also, specific controls may exist that mitigate the risk of material
misstatement due to fraud, even though risk factors or conditions
are present. When identifying risk factors and other conditions,
you should assess whether those risk factors and conditions, indi-
vidually and in combination, present a risk of material misstate-
ment of the financial statements.
Risk factors that relate to misstatements arising from misappro-
priation of assets are also classified along the three conditions
generally present when fraud exists: incentives/pressures, oppor-
tunity, and attitudes/rationalizations. Some of the risk factors re-
lated to misstatements arising from fraudulent financial reporting
also may be present when misstatements arising from misappro-
priation of assets occur. For example, ineffective monitoring of
management and weakness in internal control may be present
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when misstatements due to either fraudulent financial reporting
or misappropriation of assets exists. The following are examples
of risk factors related to misstatements arising from misappropri-
ation of assets.
Opportunities
1. Certain characteristics or circumstances may increase the
susceptibility of assets to misappropriation. For example,
opportunities to misappropriate assets increase when there
are the following:
a. Large amounts of cash payments received for medical care.
b. Pharmaceutical inventory with high street value, or in
high demand.
Auditor Responses
In addition to the sample responses presented in SAS No. 99, an
auditor may want to consider the following responses.
Cash receipts. The auditor may have identified a risk of material
misstatement relating to the potential embezzlement of cash re-
ceipts. The lack of internal accounting controls provides the op-
portunity for the embezzlement to be covered up through bad
debt, contractual, or other writeoffs. In this situation, the auditor
might expand the review of cash receipts to compare remittance
advises to accounts posted as received or might review specific ac-
counts which have been written off for appropriateness.
Kickbacks from suppliers. The auditor may have identified a risk of
material misstatement relating to potential kickbacks from suppli-
ers. Such kickbacks might result in the entity paying excessive
amounts for goods. The auditor might have concluded that the
lack of adequate internal accounting control over the purchasing
process provides the opportunity for this to occur. The auditor
might consider, in these circumstances, a more detailed analytical
review of expenses and a review of a sample of invoices to compare
amounts paid for specific items to amounts per purchase contracts
or with independent prices obtained from other vendors.
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